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Notes
REDEFINING "INTERSTATE COMMERCE" JURISDICTION
UNDER THE SHERMAN ACT: SUMMIT HEALTH, LTD.
v. PINHAS
I. INTRODUCTION
The Constitution of the United States confers on Congress the
power to regulate interstate commerce.' In an attempt to exercise its
broad regulatory power over interstate commerce, Congress enacted the
Sherman Act (the Act).2 Section 1 of the Act prohibits the undertaking
of any "contract, combination in the form of trust or otherwise, or con-
spiracy, in restraint of trade or commerce among the several States."'3
The language of section 1 evidences Congress' intent to make the juris-
dictional reach of the Act coextensive with Congress' power to regulate
commerce. 4 Therefore, in civil or criminal antitrust cases brought
1. U.S. CONST. art. I, § 8, cl. 3. Congress is given the power "[t]o regulate
Commerce . . . among the several States." Id. The United States Supreme
Court has consistently upheld Congress' power to regulate interstate commerce.
See, e.g., Katzenbach v. McClung, 379 U.S. 294, 302 (1964) (Congress' power to
regulate interstate commerce extends to retail businesses "which directly or in-
directly burden or obstruct interstate commerce"); Heart of Atlanta Motel, Inc.
v. United States, 379 U.S. 241, 255 (1964) ("[T]he determinative test of the
exercise of power by the Congress under the Commerce Clause is simply
whether the activity sought to be regulated is 'commerce which concerns more
States than one' and has a real and substantial relation to the national inter-
est."); Gibbons v. Ogden, 22 U.S. (9 Wheat.) 1, 193-94 (1824) (Congress' power
to regulate interstate commerce extends to every type of commercial intercourse
including commerce among states).
2. Sherman Act, 15 U.S.C.A. §§ 1-7 (West 1991); see also Atlantic Cleaners
& Dyers, Inc. v. United States, 286 U.S. 427, 434 (1932) (Court stated § 1 of Act
was enacted pursuant to Congress' specific power to regulate commerce).
3. Sherman Act, 15 U.S.C.A. § 1. Section 1 states:
Every contract, combination in the form of trust or otherwise, or con-
spiracy, in restraint of trade or commerce among the several States, or
with foreign nations, is declared to be illegal. Every person who shall
make any contract or engage in any combination or conspiracy hereby
declared to be illegal shall be deemed guilty of a felony, and, on convic-
tion thereof, shall be punished by fine not exceeding $10,000,000 if a
corporation, or, if any other person, $350,000 or by imprisonment not
exceeding three years, or by both said punishments, in the discretion of
the court.
Id.
4. United States v. South-Eastern Underwriters Ass'n, 322 U.S. 533, 558,
reh'g denied, 323 U.S. 811 (1944). In enacting § 1 of the Act, "Congress wanted
to go to the utmost extent of its Constitutional power in restraining trust and
monopoly agreements." Id. Senator George of the SenateJudiciary Committee,
discussing the Sherman Act, noted that "[t]he bill has been very ingeniously and
(373)
1
Detwiler: Redefining Interstate Commerce Jurisdiction under the Sherman Act
Published by Villanova University Charles Widger School of Law Digital Repository, 1992
VILLANOVA LAW REVIEW
under section 1, before jurisdiction under the Act can be invoked, a
court must determine whether the alleged restraint implicates interstate
commerce. This necessarily requires a court to define and apply the
concept of "interstate commerce" and subsequently to evaluate the na-
ture and extent of the alleged restraint's impact on interstate
commerce.
5
The boundaries of what activities constitute "interstate commerce"
have been gradually expanded and redefined by the United States
Supreme Court since the enactment of the Act over 100 years ago. 6
Through its expansion of the concept of interstate commerce, however,
the Court has concomitantly redefined and, at times, expanded the
reach of the Act. 7 Unfortunately, rather than clearly demarcating the
boundaries of the Act, the Court's redefinition of interstate commerce
has resulted in increased uncertainty with respect to the Act's jurisdic-
tional scope. 8
properly drawn to cover every case which comes within what is called the com-
mercial power of Congress." 21 CONG. REC. 3147 (1890); see also 1 PHILLIP E.
AREEDA & DONALD F. TURNER, ArTITRUST LAw 232a, at 228-29 (1978) (reach
of Act expands with broadening of federal commerce power).
5. Comment, Sherman Act 'Jurisdiction" in Hospital Staff Exclusion Cases, 132 U.
PA. L. REV. 121, 123, 128 (1983). For the purposes of this Note, when referring
to "jurisdiction" under the Act, the term addresses whether the allegedly illegal
activity has a substantial impact on interstate commerce, thus bringing it within
the purview of the Act. At the jurisdictional level, "plaintiff must show that in-
terstate commerce is implicated in some way." Id. at 122. In making its jurisdic-
tional determination, a court must ask
whether the Sherman Act "covers" the commercial activity involved.
Another way of phrasing that issue is to ask whether the parties' activity
lies within "the scope" of the Sherman Act. An activity lies within the
scope of the Act if Congress intended the proscriptions of the Act to
apply to that activity. If an activity is within the scope of the Act, a court
should apply antitrust analysis to determine if the defendant's specific
conduct violates the Sherman Act.
Id. at 128. Note, however, that "[an activity may be within the scope of the Act
and yet not violate the Act." Id. at 129.
6. Richard A. Mann, The Affecting Commerce Test: The Aftermath of McLain, 24
Hous. L. REV. 849, 850 (1987). "Whereas the United States Supreme Court has
engaged in a continual . . . trend towards expanding the jurisdictional reach of
the Sherman Act, the lower courts have undermined this tendency by adopting
conflicting interpretations of the Supreme Court's decisions." Id. (footnote
omitted). For a discussion of the judicial expansion of the concept of interstate
commerce, see infra notes 33-65 and accompanying text.
7. The Court has recognized that "[d]uring the past century, as the dimen-
sions and complexity of our economy have grown, the federal power over com-
merce, and the concomitant coverage of the Sherman Act, have experienced
similar expansion." Summit Health, Ltd. v. Pinhas, 111 S. Ct. 1842, 1846
(1991). For a further discussion of the Court's expansion of the Act's jurisdic-
tional requirement, see infra notes 33-65 and accompanying text.
8. Seglin v. Esau, 769 F.2d 1274 (7th Cir. 1985). The Seventh Circuit in
Seglin stated: "A split among the circuits exists as to whether the interstate com-
merce nexus requirement is satisfied when the plaintiff alleges that any of de-
fendants' activities affect interstate commerce or only when the plaintiff alleges
[Vol. 37: p. 373
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The most recent decision in the Court's effort to clarify the jurisdic-
tional reach of the Act is Summit Health, Ltd. v. Pinhas.9 Prior to Summit
Health, the jurisdictional reach of the Act was most recently addressed in
McLain v. Real Estate Board, Inc. 10 During the period between McLain
and Summit Health, a split in the United States Courts of Appeals had
developed over the issue of what constitutes the proper jurisdictional
reach of the Act."
In McLain, petitioners, a class of real estate buyers and sellers, al-
leged that New Orleans real estate brokers conspired to fix brokerage
commission rates in violation of the Act.12 The Court held that jurisdic-
tion under the Act would be found by a showing that the brokers' activi-
ties, which allegedly had been infected by a price-fixing conspiracy, "as a
matter of practical economics" have a "not insubstantial effect on the
interstate commerce involved."' 3
A minority of circuit courts which have addressed the issue of the
Act's jurisdictional reach after McLain have interpreted McLain as elimi-
nating the necessity of proving an actual nexus between the alleged ille-
gal restraint and its effect on interstate commerce. 14 However, the
majority of the circuits have held that the Court's opinion in McLain
does not alter the jurisdictional test under the Act. 15 Thus, under the
majority approach, the plaintiff must prove that the allegedly illegal re-
straint substantially affects interstate commerce. Recently, the Court
again addressed the issue of the scope of the Act's interstate commerce
jurisdiction in Summit Health, Ltd. v. Pinhas. 16 Summit Health provided an
opportunity for the Court to settle the confusion generated by its 1980
decision in McLain. As this Note will conclude, however, the Summit
that defendants' allegedly unlawful conduct somehow affects interstate com-
merce." Id. at 1280.
9. 111 S. Ct. 1842 (1991). For a complete discussion of Summit Health, see
infra notes 69-122 and accompanying text.
10. 444 U.S. 232 (1980). For a further discussion of McLain, see infra notes
56-65 and accompanying text.
11. For a discussion of the split in the circuits that occurred after McLain,
see infra notes 66-68 and accompanying text.
12. McLain, 444 U.S. at 234-35.
13. Id. at 246 (quoting Hospital Bldg. Co. v. Trustees of Rex Hosp., 425
U.S. 738 (1976)). For a further discussion of the Court's holding in McLain, see
infra notes 56-65 and accompanying text.
14. For a discussion of the approach taken by a minority of circuits, see
cases cited infra note 68; see also Summit Health, Ill S. Ct. at 1850 (Scalia, J.,
dissenting) (stating that minority of courts, in addressing the same issue, "took
McLain at face value" and eliminated nexus between interstate commerce and
alleged restraint).
15. For a discussion of the approach taken by the majority of the circuits,
see cases cited infra note 67; see also Summit Health, 111 S. Ct. at 1850 (Scalia, J.,
dissenting) (most courts found ultimate question was still whether unlawful con-
duct, if successful, would have substantial effect on interstate commerce).
16. 111 S. Ct. 1842 (1991). For a complete discussion of Summit Health, see
infra notes 69-122 and accompanying text.
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Health Court did not do so. 17
In Summit Health, the Court reviewed whether the interstate com-
merce jurisdictional requirement of the Act was met when Simon J.
Pinhas, M.D. (Dr. Pinhas) alleged that Summit Health, Ltd. (Summit
Health), Midway Hospital Medical Center (Midway) and its medical staff
conspired to restrain him from competing for a share of the ophthalmo-
logical services market in Los Angeles, California, in violation of section
1 of the Act.' 8 In addressing the threshold issue of whether the alleged
restraint impacted interstate commerce, the Court held that Dr. Pinhas'
claims presented sufficient evidence that the alleged restraint had the
required nexus with interstate commerce to support federal jurisdiction
under the Act. 19 In finding the required nexus, the Court employed a
new standard. This standard called for a general analysis of the effect of
the restraint on "other participants and potential participants" in the
Los Angeles ophthalmological services market.2 0 The Court's language
further muddied the waters because it did not expressly adopt one of the
competing interpretations of the jurisdictional reach of the Act.2 '
This Note will briefly trace the history of the Act from its develop-
ment and adoption through the subsequent judicial interpretation and
expansion of the Act's jurisdictional reach. This Note will address the
question of whether the Court's decision in Summit Health presents a sig-
nificant expansion of what activities constitute "interstate commerce"
under the Act or whether the decision simply refines the previous stan-
dard used by the Court in McLain. This Note will also analyze the effect
the Summit Health decision will have on jurisdictional questions arising
under the Act and how this Court's interpretation will be applied to fu-
ture section 1 actions. Finally, this Note will address Summit Health's
likely effects on the health care industry. 22 This Note will conclude that
17. See Summit Health, 111 S. Ct. at 1850 (Scalia, J., dissenting). Justice
Scalia, having noted the existence of the split, stated that "[the Court] com-
pounds the confusion by rejecting the two competing interpretations of McLain
and adding yet a third candidate to the field." Id. (Scalia, J., dissenting). For a
complete discussion of Justice Scalia's dissenting opinion, see infra notes 113-
122 and accompanying text.
18. Summit Health, 111 S. Ct. at 1844.
19. Id. at 1848-49. For a further discussion of the facts and the majority
opinion in Summit Health, see infra notes 69-112 and accompanying text.
20. Summit Health, 111 S. Ct. at 1848. The majority held, in a five to four
decision, that the relevant market from which Dr. Pinhas was excluded was the
Los Angeles ophthalmological services market. For a further discussion of Sum-
mit Health, see infra notes 69-122 and accompanying text.
21. For a further discussion of the competing interpretations of the juris-
dictional reach of the Act, see infra notes 66-68 & 127-37 and accompanying
text.
22. The jurisdictional issue is especially important in the health care indus-
try. The health care industry is generally characterized as having "local fea-
tures." Thus, the broader the Court interprets the jurisdictional reach of the
Act, the more it will further the main purpose of antitrust laws, which is to com-
pel competition and, ultimately, to lower health care costs. For a further discus-
376 [Vol. 37: p. 373
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Summit Health establishes a new and expanded jurisdictional standard for
section 1 of the Act.
II. BACKGROUND
A. The Genesis of the Sherman Act
The Sherman Act was enacted in response to fundamental changes
in the American economy following the Civil War. 23 As the postwar in-
dustrial expansion developed in earnest, economic competition in-
creased among businesses.2 4  Public resentment toward these
organizations generated a political and social debate that eventually in-
volved the executive and legislative branches of the federal govern-
ment.2 5 The cry for antitrust legislation found support in both political
parties.2 6 On August 14, 1888, Senator John Sherman of Ohio intro-
duced to the Fiftieth Congress his initial antitrust legislation, Senate Bill
sion of the implications of the Court's decision in Summit Health for the health
care industry, see infra notes 156-72 and accompanying text.
23. I EARL W. KINTNER, THE LEGISLATIVE HISTORY OF THE FEDERAL ArI-
TRUST LAwS AND RELATED STATUTES 9-12 (ed. 1978).
24. I KINTNER, supra note 23, at 9. This rapid industrialization of the United
States was noted by SenatorJones, in the Senate debates on the Act, as changing
the complexion of the economy from what it was when the Constitution was
adopted. 20 CONG. REC. 1457 (1889). He stated:
Whether, if this vast and intricate system of "commerce among the
States" had been comprehended in all its immensity by the framers of
the Constitution, this power of control, unlimited save by the discretion
of Congress, would have been conferred upon us we may well doubt;
and, doubting this, we should proceed with caution in the exercise of
this great power.
Id.
Pools and trusts, which at the time were new forms of American business
organizations, were formed in an attempt to harness a competitive, and some-
times dominant, edge in many different industries. I KINTNER, supra note 23, at
10. A "pool" was a joint agreement between competitors "to divide markets,
share profits, discriminate jointly against less-favored entities, and otherwise
wield their economic power." Id. at 10. Pools were unstable arrangements due
to their voluntary nature and lack of enforceability. Id. Trusts provided a more
stable organization whereby the member corporations would typically transfer
their stock to a separate board of trustees. Id. The board would assume full
control over the trust giving the member corporations trust certificates in return
for their shares and the right to receive a pro-rata share of the trust's profits. Id.
25. I KINTNER, supra note 23, at 11-12. Small business owners and the gen-
eral public began to despise these organizations as they brutally crushed compe-
tition and caused consumer prices to rise. Id. at 11. The public resentment
towards these organizations became an important political issue as the 1888
elections approached. Id. at 13. Resolutions were introduced into the Fiftieth
Congress that allowed for the investigation of pools and trusts and the genera-
tion of appropriate legislation. Id.
26. Id. at 12-13. At the time, the Democrats, who typically supported fewer
restrictions on foreign trade, protested against the trusts and the government's
protective trade policy. Id. at 12. The Republican Party, also known as the
"Party of Big Business," may have supported the antitrust legislation as a way to
combat the public outrage towards the trusts. Id. at 12-13.
1992] 377NOTE
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3445.27 The Senate's deliberations on Senator Sherman's bill primarily
focused on the source and scope of Congress' authority to regulate in-
terstate commerce, and the constitutionality of the bill. 28 The Fifty-First
Congress, in debating Senator Sherman's Senate Bill 1 (identical to Sen-
ate Bill 3445), addressed similar concerns regarding the constitutional-
ity of such legislation. 29 Finally, on July 2, 1890, President Benjamin
Harrison signed Senate Bill 1 into law, leaving the issue of the Act's
jurisdictional scope to the courts. 30
27. Id. at 14. The Senate bill consisted of a single section that was entitled:
"To declare unlawful trusts and combinations in restraint of trade and produc-
tion." S. 3445, 50th Cong., Ist Sess. (1888), reprinted in I KINTNER, supra note 23,
at 63-64. On September 11, 1888, the Senate Committee on Finance sent back a
revised version of Senate Bill 3445, which provided in part:
[A]ll arrangements, contracts, agreements, trusts, or combinations be-
tween persons or corporations made with a view, or which tend, to pre-
vent full and free competition in the importation, transportation, or
sale of articles imported into the United States or in the production,
manufacture, or sale of articles of domestic growth or production, or
domestic raw material ... which shall be transported from one State or
Territory to another. . . are hereby declared to be against public policy,
unlawful, and void.
S. 3445, 50th Cong., 1st Sess. (1888) (as reported by the Senate Committee on
Finance), reprinted in I KINTNER, supra note 23, at 65-66.
28. 20 CONG. REC. 1167 (1889), reprinted in I KINTNER, supra note 23, at 69.
Senator Sherman stated that the Bill would go
as far as the Constitution permits Congress to go, because it only deals
with two classes of matters: contracts which affect the importation of
goods into the United States, which is foreign commerce, and contracts
which affect the transportation and passage of goods from one State to
another. The Congress of the United States can go no farther than
that.
Id.
29. Representative Culberson of Texas, summarizing the prevailing view
on Congress' ability to regulate interstate commerce, stated that the Act ad-
dressed a new area of legislation, "and as the Constitution has wisely left with
the several States of this Union the right to local self-government, the legislative
field of Congress with reference to questions of this character, except in a few
instances where power has been granted to the Federal or General Government,
is extremely limited." 21 CONG. REC. 4089 (1890), reprinted in I KINTNER, supra
note 23, at 299. Representative Culberson also expressed uncertainty regarding
the scope of the Act, adding that "just what contracts, what combinations in the
form of trusts, or what conspiracies will be in restraint of the trade or commerce
mentioned in the bill will not be known until the courts have construed and
interpreted this provision." Id. Senator Gray added that he could not vote for a
bill that exercises powers not given to Congress by the Constitution. Id. at 2657.
Senator Reagan of Texas stated, on the subject of restraints of trade, that
Congress does not have a limited power; but the exercise of its power
under the Constitution and the doing of what it may do rightfully under
the Constitution will not give relief to the people of the country unless
the Legislatures of the several States take hold of the subject and make
provisions there which will cover the larger number and the greater
amount of the wrongs complained of by the people.
21 CONG. REC. at 2470; see also id at 2566 (Senator Stewart of Nevada stated: "I
find no warrant in the Constitution for Congress to pass this kind of a law.").
30. I KINTNER, supra note 23, at 30.
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The Act's jurisdictional scope has been substantially expanded by
courts in the intervening years, 3 1 while the text of the Sherman Act has
remained virtually unchanged since its promulgation in 1890.32
B. The Expansion of Jurisdiction Under the Sherman Act
One of the Supreme Court's first decisions addressing the jurisdic-
tional scope of the Act was United States v. E.C. Knight Co. 33 In E.C.
Knight, the Court interpreted the Act's jurisdictional reach narrowly,
holding that manufacturing did not impact interstate commerce.3 4 This
decision was significant because the Court rendered its decision without
reaching the merits of the case. Effectively, the Court bifurcated the ju-
risdictional and substantive aspects of the "interstate commerce" in-
quiry under the Act. 3 5 It is noteworthy, however, that the plain
language of the Act makes no mention of separating the jurisdictional
and substantive aspects of the "interstate commerce" analysis. 3 6
In Addyston Pipe & Steel Co. v. United States,3 7 the Court expanded the
"interstate commerce" jurisdiction of the Act to include restraints of
31. For a discussion of this expansion, see infra notes 33-65 and accompa-
nying text.
32. I KINTNER, supra note 23, at 30. Commentators suggest that "it is
largely because of its general terms evoking Congress' plenary commerce power
that the Sherman Act has served essentially without alteration as the cornerstone
of American antitrust law." Id.
33. 156 U.S. 1 (1895); see Mandeville Island Farms, Inc. v. American Crystal
Sugar Co., 334 U.S. 219, 229 (1948) (Knight was "the first decision under the
Sherman Act").
34. Knight, 156 U.S. at 17. In Knight, a NewJersey corporation, already con-
trolling a majority of the domestic refined sugar market, purchased stock of four
Philadelphia sugar refineries. Id. at 9. The Court held that the purchase created
a monopoly in the manufacture of sugar, but not a monopoly within the scope of
Act. Id. at 17. The Court held that "the contracts and acts of the defendants
related exclusively to the acquisition of the Philadelphia refineries and the busi-
ness of sugar refining in Pennsylvania, and bore no direct relation to commerce
between the States." Id. Therefore, it was not within the scope of the Act. Id.
The Court further held that manufacturing did not "put a restraint upon
trade or commerce," therefore the Court could not grant jurisdiction under the
Act. Id. The Court stated, "it does not follow that an attempt to monopolize...
the manufacture was an attempt, whether executory or consummated, to mo-
nopolize commerce even though, in order to dispose of the product, the instru-
mentality of commerce was necessarily invoked." Id.
35. 1 AREEDA & TURNER, supra note 4, 232c, at 231. These commentators
posit that "the Court never reached the merits of the government's case because
the constitutional determination was made first, and the courts still treat the
commerce question as a preliminary jurisdictional hurdle in antitrust litigation."
Id.
36. The Act does not specifically refer to the jurisdictional or substantive
aspects of an alleged restraint. The Act simply states that "[elvery person who
shall make any contract or engage in any combination or conspiracy hereby de-
clared to be illegal shall be deemed guilty of a felony." 15 U.S.C.A. § 1 (West
1991). For the full text of § 1, see supra note 3.
37. 175 U.S. 211 (1899).
1992] 379NOTE
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trade that not only restrain manufacturing, but also the purchase and
sale of manufactured products between several states.3 8 This decision
went well beyond the Court's holding in E.. Knight. Furthermore, the
United States Court of Appeals for the Sixth Circuit in Addyston Pipe held
that the alleged restraint was unlawful under both the common law and
the Act.3 9 Writing for the Sixth Circuit, Judge Taft held that, where the
intent of the parties to an agreement is to restrain trade and competi-
tion, the agreement is void. 40 The Supreme Court generally affirmed
the Sixth Circuit's opinion with only minor modification.
38. Id. at 241-42. In Addyston Pipe, domestic iron pipe manufacturers com-
bined to divide their territory into "reserved" cities and "pay" territory. Id. at
213-14, 218. The "reserved" cities were apportioned to specific members of the
combination, free from any true competition. Id. In these cities, other members
of the combination submitted sham bids at pre-arranged prices, in order to in-
troduce evidence of competition. Id. In the "pay" territories, any offers to buy
pipe were reviewed by a committee of the combination's members. Id. The
committee fixed the contract price and awarded the contract to the member
which offered to pay the largest "bonus." Id. This bonus was split between the
other members of the combination. Id. The combination's alleged sole purpose
was to raise the price for their iron pipe. Id. at 213.
39. United States v. Addyston Pipe & Steel Co., 85 F. 271, 279 (6th Cir.
1898), modified, 175 U.S. 211 (1899). The defendants contended that the combi-
nation was valid under common law. Id. at 278. Furthermore, defendants ar-
gued that their combination was not void under the Act since the Act was not
intended to void any agreements that were enforceable under common law. Id.
Circuit Judge Taft's opinion presented a clear and concise survey of the
common law that served as the Act's foundation. Judge Taft noted that English
courts of equity refused to enforce even voluntary restraints of trade for a variety
of reasons. Id. at 279. One reason was that voluntary restraints prevented peo-
ple "from earning a livelihood with the risk of becoming a public charge, and
deprived the community of the benefit of his labor." Id. The second reason
given was that "such restraints tended to give to the covenantee, the beneficiary
of such restraints, a monopoly of the trade, from which he had thus excluded
one competitor, and by the same means might exclude others." Id.
The common law eventually settled on a standard that analyzed the legality
of an alleged restraint in terms of whether it was "reasonable in the light of
accepted business conduct and merely incidental to arrangements primarily
designed to carry out such conduct, or whether [it] exceeded the acceptable lim-
its so as to constitute unreasonable restraints upon commercial activity." I KINT-
NER, supra note 23, at 8 (citing 1 HARRY AUBREY TOULMIN, JR., A TREATISE ON
THE ANTI-TRUST LAws OF THE UNITED STATES 24-92, §§ 2.14-.17 (1949)); see also
William L. Letwin, The English Common Law Concerning Monopolies, 21 U. CHI. L.
REV. 355, 378 (1954) (reasonableness referred specifically to whether restraint
was reasonable to interests of affected parties, and to interests of public).
Judge Taft noted that American courts of equity, such as the Supreme Judi-
cial Court of Massachusetts, in Alger v. Thacher, restated similar objections to
"the unreasonableness of contracts in restraint of trade and business." Addyston
Pipe, 85 F. at 280 (quoting Alger v. Thacher, 36 Mass. (19 Pick.) 51, 54 (1837)).
Such contracts were held to be void and unenforceable. Addyston Pipe, 85 F. at
280. Judge Taft interpreted the Act to render such restraints illegal and punish-
able as a misdemeanor. Id.
40. Addyston Pipe, 85 F. at 291-94.
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1. The Continued Expansion and Development of the Flow of Commerce Test
Following Addyston Pipe, the Court decided two cases, Swift & Co. v.
United States41 and United States v. South-Eastern Underwriters Association,4 2
which substantially expanded the jurisdictional scope of the Act. In
Swift, Justice Holmes developed the "flow of commerce" test, which ex-
panded the Act's jurisdictional scope to include commercial transactions
no matter how far removed from interstate transactions. 43 The test was
premised on an expectation that goods which are sent for sale will even-
tually end up in another state, and that the practice was "constantly re-
curring."' 44 Accordingly, the Court found jurisdiction because of the
interstate shipment of the goods at issue (the cattle), even though the
alleged restraint (the price-fixing agreement) occurred in a single
state.4 5 Under the "flow of commerce" test, Justice Holmes described
41. 196 U.S. 375 (1905). For a discussion of Swift, see infra notes 43-46
and accompanying text.
42. 322 U.S. 533 (1944). For a discussion of South-Eastern, see infra notes
47-51 and accompanying text.
43. 1 AREEDA & TURNER, supra note 4, 232c, at 231; see Swift, 196 U.S. at
398-99 (item enters "current of commerce" when it is sent for sale from one
state to another state, with expectation it will be sold to buyer from another
state). In Swift, the defendants were engaged in the business of buying livestock
at midwestern stockyards and slaughtering the livestock at their plants through-
out the Midwest. Id. at 391. The defendants then sold the fresh meat from their
plants to suppliers and consumers in other states. Id. The defendants allegedly
engaged in a combination that required that the defendants' purchasing agents
at the stockyards not bid against each other. Id. The agreement resulted in the
livestock owners selling at lower prices than they would have received under
competitive bidding. Id.
The Court granted jurisdiction under the Act because defendants regularly
transported livestock across state lines to slaughterhouses. Id. at 398. Here, the
Court found a nexus between the illegal price-fixing agreement and the inter-
state shipments of the purchased livestock. Id. at 398-400. As Justice Holmes
concluded, the Act was implicated because the livestock entered the "flow of
commerce" when they were shipped across state lines to the slaughterhouses.
Id. at 398-99.
44. Swift, 196 U.S. at 399. Justice Holmes explained the application of the
test to the facts in Swift as:
When cattle are sent for sale from a place in one State, with the expec-
tation that they will end their transit, after purchase, in another, and
when in effect they do so, with only the interruption necessary to find a
purchaser at the stock yards, and when this is a typical, constantly re-
curring course, the current thus existing is a current of commerce among the
States, and the purchase of the cattle is a part and incident of such
commerce.
Id. at 398-99 (emphasis added).
45. Id. at 399-400. Commentators have interpreted the Swift test as con-
sisting of two general "flow" rules: "(1) goods enter the flow of commerce
when dispatched for sale with the understanding of both parties that they are
destined for transport to another state; (2) the flow ends when goods are trans-
formed in a material way." 1 AREEDA & TURNER, supra note 4, 233b, at 243. If
these flow rules are met, then according to commentators, federal jurisdiction
will attach. Id.
1992] NOTE
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the jurisdictional analysis under section 1 of the Act as "not a technical
legal conception, but a practical one, drawn from the course of busi-
ness." 4 6 As posited byJustice Holmes, the "flow of commerce" test rep-
resented a substantial expansion of the jurisdictional reach of the Act.
Almost 40 years after Swift, the Court decided United States v. South-
Eastern Underwriters Association.47 In South-Eastern, the defendant, an asso-
ciation of fire insurance companies, was charged with conspiring to fix
premium rates and sales agents' commissions and conducting boycotts
to force other fire insurance companies into the conspiracy. 4 8 South-
Eastern argued that Congress did not intend the Act's jurisdiction to
extend to interstate insurance transactions. 4 9 Again, the Court applied
the "flow of commerce" test and found that the price-fixing conspiracy
restrained interstate trade. 50 The Court's decision was a notable expan-
sion of the Act's jurisdictional reach because of its observation that the
plain language of the Act "shows a carefully studied attempt to bring
within the Act every person engaged in business whose activities might
restrain or monopolize commercial intercourse among the states." 5 1
2. From the "Flow" to the "Effects" Test
Mandeville Island Farms, Inc. v. American Crystal Sugar Co. 5 2 represents
an important shift in the Supreme Court's view of the Act's jurisdictional
46. Swift, 196 U.S. at 398. Commentators credit Holmes' opinion in Swift
with originating the "flow of commerce" test. 1 AREEDA & TURNER, supra note 4,
233b, at 242.
47. 322 U.S. 533 (1944). Although there is a forty-year gap between Swft
and South-Eastern, South-Eastern represents the next noteworthy refinement of the
jurisdiction test for interstate commerce under the Act.
48. South-Eastern, 322 U.S. at 534-35. South-Eastern Underwriters Associa-
tion (SEUA) was composed of 200 private stock fire insurance companies and 27
individuals. Id. at 534. The member companies of SEUA controlled 90% of the
fire insurance in the six states where the conspiracy was centered. Id. at 535.
Corporations that did not join South-Eastern were unable to reinsure their poli-
cies and had their reputations disparaged. Id. at 535. The conspiracy was po-
liced by state and local insurance rating boards. Id. at 536. The purpose of the
conspiracy was to force persons in need of insurance to buy only from a SEUA
company on SEUA's terms. Id. at 535.
49. Id. at 553. The Court disagreed and held that there was no evidence
that "the Congress of 1890 specifically intended to exempt insurance companies
from the all-inclusive scope of the Sherman Act." Id. at 560.
50. Id. at 550. Although the Court did not use the precise terminology
"flow of commerce," it stated that "[p]remiums collected from policyholders in
every part of the United States flow into these companies for investment. As
policies become payable, checks and drafts flow back to the many states where
the policyholders reside. The result is a continuous and indivisible stream of inter-
course among the states." Id. at 541 (emphasis added).
51. Id. at 553. This interpretation appears to be consistent with the intent
of the Act's drafters, because Senator Sherman stated that "I do not wish to
single out any particular trust or combination. It is not a particular trust, but the
system I [aim] at." 21 CONG. REC. 2457 (1890).
52. 334 U.S. 219 (1948).
10
Villanova Law Review, Vol. 37, Iss. 2 [1992], Art. 4
https://digitalcommons.law.villanova.edu/vlr/vol37/iss2/4
19921 NOTE
scope. 5 3 The Court, in analyzing jurisdiction, made a fundamental shift
from the "flow" test to the "effects" test, stating that "the vital thing is
the effect on commerce, not the precise point at which the restraint oc-
curs or begins to take effect." 54 This shift expanded the scope of the
Act to reach any and all restraints "affecting commerce," and set the
stage for the current confusion over the jurisdictional scope of the
Act. 5
5
53. The plaintiffs, northern California sugar beet growers, contracted with
one of three beet refiners to grow beets and sell the entire harvest to the refiner,
pursuant to the standardized contract. Id. at 222. The growers were required to
buy the sugar beet seeds from the refiners, because the refiners controlled the
supply of the seeds. Id. The contracts controlled where the seeds were planted
and gave the refiners the right to supervise all aspects of the harvest, including
quality inspections. Id. at 222-23. The three refiners entered into an agreement
to pay uniform prices for sugar beets. Id. at 223. Since the refiners essentially
controlled all aspects of the market, the growers were forced to sign with one of
the three refiners or abandon the industry. Id.
The Court considered whether a price-fixing arrangement among sugar re-
finers was within the jurisdictional scope of the Act. Id. at 221-22. The Court
held that a price-fixing agreement between California sugar beet farmers vio-
lated the Act even though beets were processed into sugar before being distrib-
uted into interstate commerce. Id. at 235.
54. Id. at 238. The Court applied the "effects" test and looked at the gen-
eral business activities of the sugar refiners. Id. at 242. Although the alleged
restraint, a price-fixing agreement, was solely an intrastate transaction, "the re-
straint and its monopolistic effects were reflected throughout each state of the
industry, permeating its entire structure." Id. The Court found two distinct in-
terstate effects produced by the illegal agreements. Id. at 240. One was that the
price paid to the growers was "devoid of all competitive influence in amount."
Id. at 240-41. The second was that the agreements reduced competition in the
overall interstate distribution of sugar, since the sugar is sold to out-of-state pur-
chasers. Id. at 241.
It should be noted that the Court previously had invoked language sug-
gesting that it would examine the "effect" of an illegal restraint on interstate
commerce. In Apex Hosiery Co. v. Leader, the Court considered jurisdiction by
"the nature of the restraint and its effect on interstate commerce and not the
amount of the commerce." Apex Hosiery Co. v. Leader, 310 U.S. 469, 485
(1940) (citing United States v. Socony-Vacuum Oil Co., 310 U.S. 150 (1940)); see
also 1 AREEDA & TURNER, supra note 4, 232d, at 232-34. The authors noted
that "the Court abandoned the direct-indirect effects distinction, and articulated
a new concept of the Sherman Act's commerce requirement. Rather than focus-
ing on the location of the defendant's conduct, the Court emphasized the effects
of that conduct." Id. at 232.
55. 1 AREEDA & TURNER, supra note 4, 232d, at 232-33. The Court's shift
from the "flow" test to the "effects" test erased the distinction between jurisdic-
tional and substantive issues under the Act. Id. at 232. Jurisdiction under the
"flow" test was determined by defining the geographic location of the alleged
illegal restraint. Id. at 232-33. If the restraint was in the "flow of commerce,"
the court could address the substantive issue(s), which sometimes required sepa-
rate standards of proof. Id. Under the "effects" test in Mandeville Island, the
Court held that the alleged restraint violated the Act as long as the Court had
jurisdiction, which now had to be proved by the existence of an interstate effect
on commerce. Mandeville Island, 334 U.S. at 242; see also I AREEDA & TURNER,
supra note 4, 232d, at 233.
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3. McLain v. Real Estate Board, Inc.
The Court's decision in McLain v. Real Estate Board, Inc. 5 6 created
significant controversy regarding Sherman Act jurisdiction. 5 7 In Mc-
Lain, petitioner, representing a class of real estate purchasers and sell-
ers, alleged that the Real Estate Board of New Orleans (the Board)
conspired to fix the rate of brokerage commissions on the sale of resi-
dential property.5 8 McLain claimed that the Board's alleged restraint
"injured [the class] in their business or property because the fees and
commissions charged for brokerage services ha[d] been maintained at
an artificially high and noncompetitive level, with the effect that the
prices of residential properties ha[d] been artificially raised."'59
In addressing the jurisdictional issue of whether the alleged con-
duct sufficiently impacted interstate commerce, the Court in McLain
held that "[t]o establish federal jurisdiction . . .there remains only the
requirement that respondents' activities which allegedly have been in-
fected by a price-fixing conspiracy be shown 'as a matter of practical
economics' to have a not insubstantial effect on the interstate commerce
involved."'60 Plaintiffs, under the Sherman Act, need not make a "more
56. 444 U.S. 232 (1980).
57. Summit Health, Ltd. v. Pinhas, 111 S. Ct. 1842, 1850 (1991) (Scalia, J.,
dissenting).
58. McLain, 444 U.S. at 235.
59. Id. McLain sought injunctive relief and treble damages. Id.
60. Id. at 246 (quoting Hospital Bldg. Co. v. Trustees of Rex Hosp., 425
U.S. 738, 745 (1976)). In Hospital Building, Hospital Building Co. (Hospital),
which operated a 49-bed hospital in Raleigh, North Carolina, alleged that the
trustees of Rex Hospital (Rex), a private, tax-exempt hospital in Raleigh, con-
spired to block Hospital from relocating and expanding in Raleigh. Hospital
Bldg., 425 U.S. at 740. The complaint alleged that approximately 80% or
$112,000 of Hospital's medical supplies were provided by out-of-state vendors.
Id. at 741. More importantly, a large portion of Hospital's revenue was from
out-of-state insurance companies or from the federal government. Id. Hospital
also claimed that a sizable number of Hospital's patients came from out-of-state.
Id. Hospital was also paying a management fee to Hospital's out-of-state parent
company. Id.
In passing on the application of the Act to the facts averred by Hospital, the
Court stated that a restraint can be local in nature yet still meet the required
interstate commerce nexus, "[a]s long as the restraint in question 'substantially
and adversely affects interstate commerce.' " Id. at 743 (quoting Gulf Oil Corp.
v. Copp Paving Co., 419 U.S. 186, 195 (1974); United States v. Employing Plas-
terers Ass'n, 347 U.S. 186, 189 (1954)).
The Court stated that even though the effect on interstate commerce might
be characterized as " 'indirect' because the conduct producing it is not 'pur-
posely directed' toward interstate commerce [that] does not lead to a conclusion
that the conduct at issue is outside the scope of the Sherman Act." Id. at 744.
The Court held that the combination of the interstate effects alleged by
Hospital was "sufficient to establish a 'substantial effect' on interstate commerce
under the Sherman Act." Id. The Court held that the applicable test was
whether the alleged restraint substantially affected interstate commerce "as a
matter of practical economics." Id. at 744-45; see also Goldfarb v. Virginia State
Bar, 421 U.S. 773, 784 (1975); Burke v. Ford, 389 U.S. 320, 321-22 (1967).
384 [Vol. 37: p. 373
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particularized showing of an effect on interstate commerce by the al-
leged conspiracy." 6 1 Accordingly, the Court vacated the Fifth Circuit's
opinion, which had affirmed the district court's dismissal of McLain's
complaint, and remanded the case.
62
The McLain decision is significant in the jurisprudence of the Act
for two reasons. First, implicit in the McLain Court's holding is the idea
that interstate commerce has to be proven twice, once at the jurisdic-
tional level and then again at trial.6 3 Second, the Court states that "the
jurisdictional requirement of the Sherman Act may be satisfied under
either the 'in commerce' or the 'effect on commerce' theory."' 64 This is
The Court in McLain determined that the broker's main purpose was to fa-
cilitate the reaching of an agreement between the buyer and seller of residential
property. McLain, 444 U.S. at 246. The broker charged fees for this service
based on a percentage of the sale price. Id. The Court held that since a broker's
tactics "necessarily affect both the frequency and the terms of residential sales
transactions," any action affecting the sales volume necessarily affects the de-
mand for financing and title insurance, which are "two commercial activities that
on this record [were] shown to have occurred in interstate commerce." Id.
61. McLain, 444 U.S. at 242. The Court determined that if the jurisdic-
tional test required a plaintiff to prove the alleged restraint had an effect on
interstate commerce, jurisdiction would be blocked if the defendant could show
that the alleged restraint failed to have its intended anticompetitive effect. Id. at
243.
In reaching this holding, the Court expressly disagreed with the lower
court's application of Goldfarb v. Virginia State Bar. McLain, 444 U.S. at 244-45.
Goldfarb involved plaintiff home-buyers' effort to hire a local attorney to conduct
a title examination for less than the minimum fee proposed by the county bar
association. Goldfarb, 421 U.S. at 775-76. Plaintiffs sued under § 1 of the Act,
alleging the minimum-fee schedule was a violation. Id. at 775. The Court estab-
lished jurisdiction by finding that a title examination was substantially within the
stream of interstate commerce. Id. at 784-85. The Court in McLain stated that
"[tihe Goldfarb holding was not addressed to the 'effect on commerce' test of
jurisdiction and in no way restricted it to those challenged activities that have an
integral relationship to an activity in interstate commerce." McLain, 444 U.S. at
244.
62. McLain, 444 U.S. at 247.
63. Id. at 242-43. The Court held that jurisdiction will be granted if plain-
tiffs "demonstrate a substantial effect on interstate commerce generated by [de-
fendants'] brokerage activity." Id. at 242. "[L]iability may be established by
proof of either an unlawful purpose or an anticompetitive effect." Id. at 243.
Interstate commerce jurisdiction, as "one of the requisites of a cause of action"
under the Act, is proved by "a demonstrable nexus between the defendants'
activity and interstate commerce." Id. at 246. The Court held that such a show-
ing was sufficient "for satisfying the Act's jurisdictional requirements under the
effect-on-commerce theory so as to entitle the petitioners to go forward." Id. at
246-47.
64. Id. at 242 (citing Hospital Bldg., 425 U.S. at 743). The Court added that
[t]o establish jurisdiction a plaintiff must allege the critical relationship
in the pleadings and if these allegations are controverted must proceed
to demonstrate by submission of evidence beyond the pleadings either
that the defendants' activity is itself in interstate commerce or, if it is
local in nature, that it has an effect on some other appreciable activity
demonstrably in interstate commerce.
Id. (citing Gulf Oil Corp. v. Copp Paving Co., 419 U.S. 186, 202 (1974)). The
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significant because the conceptual difference between the two themes is
that the "effect on commerce" theory encompasses a broader range of
activity. Its burden of proof is a showing that the defendant's business
activities which are allegedly infected by an illegal restraint "as a matter
of practical economics" have "a not insubstantial effect on the interstate
commerce involved. ' 65
4. The Circuit Split After McLain
As a result of the patent ambiguity in the McLain opinion, a jurisdic-
tional split has developed between the circuit courts that have decided
Sherman Act cases since McLain.66 A majority of the courts interpret
McLain as holding that the jurisdictional test is whether the "particular"
alleged restraint has a substantial effect on interstate commerce. 6 7
Court held, in discussing the burden of proof at the jurisdictional level, that "[it
is axiomatic that a complaint should not be dismissed unless 'it appears beyond
doubt that the plaintiff can prove no set of facts in support of his claim which
would entitle him to relief.'" Id. at 246 (quoting Conley v. Gibson, 355 U.S. 41,
45-46 (1957)).
65. Id. (quoting Hospital Bldg., 425 U.S. at 745).
66. See Summit Health, 111 S. Ct. at 1850 (Scalia, J., dissenting). See generally
PHILLIP E. AREEDA & HERBERT HOVENKAMP, ANTITRUST LAw, 232. lc, at 254-55
(Supp. 1990).
67. See, e.g., Crane v. Intermountain Health Care, Inc., 637 F.2d 715, 724
(10th Cir. 1980). "[W]e do not believe McLain signals a shift in analytical focus
away from the challenged activity and towards the defendant's general or overall
business." Id. at 724; see also Stone v. William Beaumont Hosp., 782 F.2d 609,
613-14 (6th Cir. 1986) (holding that jurisdiction depends on showing allegedly
unlawful conduct infected general business activities of defendant affecting or
likely to affect interstate commerce) (citing Furlong v. Long Island Hosp., 710
F.2d 922, 926 (2d Cir. 1983)); Seglin v. Esau, 769 F.2d 1274, 1280 (7th Cir.
1985) (same); Hayden v. Bracy, 744 F.2d 1338, 1343 (8th Cir. 1984) ("For fed-
eral jurisdiction to arise, the antitrust plaintiff must show that the alleged re-
straint would tend, ' "as a matter of practical economics" to have a not
insubstantial effect on the interstate commerce involved.' " (quoting McLain,
444 U.S. at 246) (footnote omitted)); Furlong, 710 F.2d at 926 ("[I]t would not
be prudent to extract from McLain a generalized rule that antitrust jurisdiction
can be established simply by showing that some aspects of a defendant's busi-
ness have a relationship to interstate commerce."); Cordova & Simonpietri Ins.
Agency, Inc. v. Chase Manhattan Bank, N.A., 649 F.2d 36, 44 (1st Cir. 1981) ("It
is well established that to satisfy the 'interstate commerce' requirements of these
provisions, the challenged activity must either occur 'in interstate commerce' or
'while wholly local in nature, nevertheless substantially affect interstate com-
merce.'" (quoting McLain, 444 U.S. at 241)).
The facts in Seglin are nearly identical to the facts in Summit Health. The
court in Seglin affirmed the dismissal of an antitrust claim on the grounds of lack
of subject matter jurisdiction and failure to state a claim. Seglin, 769 F.2d at
1274. Seglin, a member of defendant hospital's physician staff, whose staff privi-
leges were revoked, brought an antitrust action against the hospital. Id. at 1275-
76. Seglin alleged that since some of the defendant's business activities affected
interstate commerce, his claim was within the scope of the Act. Id. at 1280.
The court held, on the basis of Furlong and Cordova, that the Act's jurisdic-
tional requirement cannot be "established simply by 'showing that some aspects
of a defendant's business have a relationship to interstate commerce.' " Id.
386
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Thus, under the majority's reading of McLain, the test for jurisdiction
remains unchanged. These courts hold that to gain federal jurisdiction
under the Act, the plaintiff must show that the unlawful activity itself has
a substantial effect on interstate commerce. However, a minority of
courts interpret McLain as greatly expanding the reach of the Act and
holding that jurisdiction is established under the Act by a mere showing
that the general business activities of the defendant have a substantial
effect on interstate commerce. 6 8 It is against this backdrop of confusion
in the circuit courts that Summit Health was decided by the Court.
(quoting Furlong, 710 F.2d at 926). The Seglin court stated that it would follow
"the First, Second, Eighth, and Tenth Circuits and hold that 'the inquiry must be
whether the defendants' activity that has allegedly been "infected" by unlawful
conduct can be shown "as a matter of practical economics" to have had a not
insubstantial effect on the interstate commerce involved.' " Id. at 1280 (quoting
Furlong, 710 F.2d at 926 (quoting McLain, 444 U.S. at 246)).
68. See, e.g., Mitchell v. Frank R. Howard Memorial Hosp., 853 F.2d 762,
765 (9th Cir. 1988) ("[W]hether a hospital's activities sufficiently affect interstate
commerce to create Sherman Act jurisdiction is a highly fact-based question ....
"), cert. denied, 489 U.S. 1013 (1989); Shahaway v. Harrison, 778 F.2d 636, 641
(1 I th Cir. 1985) ("U]urisdiction requires allegations that defendant's business
activities have a substantial impact on interstate commerce."); Cardio-Medical
Assocs. v. Crozer-Chester Medical Ctr., 721 F.2d 68, 74-75 (3d Cir. 1983) (for
jurisdictional purposes court considered "defendant's conduct both as it affects
interstate commerce through the person of the plaintiff and as it affects com-
merce directly"); Western Waste Serv. Sys. v. Universal Waste Control, 616 F.2d
1094, 1097 (9th Cir.) (Universal's rubbish collection business "substantially af-
fected interstate commerce" independent of the alleged restraints), cert. denied,
449 U.S. 869 (1980). But see, e.g., AREEDA& HOVENKAMP, supra note 66, 232.1c,
at 254-55. These commentators argue that the Ninth Circuit in Western Waste
misinterpreted McLain. "[Tihe [C]ourt made clear that there must be a nexus,
at least 'as a matter of practical economics' between the challenged conduct and
interstate commerce." Id. (quoting McLain, 444 U.S. at 246).
In McLain, the Court held that "to establish jurisdiction [under the Act] a
plaintiff must [show] . .. either that the defendants' activity is itself in interstate
commerce or, if it is local in nature, that it has an effect on some other apprecia-
ble activity demonstrably in interstate commerce." McLain, 444 U.S. at 242.
The Ninth Circuit, in Mitchell, affirmed the lower court's dismissal of the
plaintiff-doctor's antitrust claim under the Act. Mitchell, 853 F.2d at 765-66.
Mitchell, a radiologist, sued the defendant-hospital because the hospital termi-
nated its contract with Mitchell and entered into an exclusive agreement with
another radiologist. Id. at 763. In affirming the lower court's opinion, the Ninth
Circuit interpreted McLain and Western Waste as requiring for jurisdiction under
the Act that the " 'general business' activities test which requires examination of
all of the Hospital's business activities." Id. at 764 n. .
The Third Circuit, in Cardio-Medical Associates, used the "substantial and ad-
verse effect" on interstate commerce test. Cardio-Medical Assocs., 721 F.2d at 75.
The court stated that "[wie agree that the decisions in McLain and Hospital Build-
ing Co. do not require any particular type of substantial effect on commerce." Id.
at 72. The Third Circuit was unwilling to follow the district court's requirement
of proof of the net effect on the hospital's flow of commerce into and out of the
state. Id. at 73.
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III. SUMMIT HEALTH LTD. V. PINHAS
A. Facts
In Summit Health,69 Dr. Pinhas was a member of the medical staff of
Midway Hospital from October 1981 until April 1987.70 Dr. Pinhas was
a widely respected and successful specialist in corneal eye surgery, per-
forming general eye surgery, cornea transplants, cataract removal, and
interocular lens replacement.
7 1
Prior to February 1986, the common procedure at Midway Hospital
and other Los Angeles County hospitals was to have eye surgeries per-
formed by a primary surgeon and a second, assistant surgeon. 72 This
practice significantly increased the cost of these procedures. 7 3 In Febru-
ary 1986, Medicare, the federal health insurance program for the eld-
erly, concluded that assistant surgeons were not necessary to the
successful completion of these surgical procedures and terminated reim-
bursement for the cost of assistant surgeons.74 While nearly all South-
69. 111 S. Ct. 1842 (1991). Because Summit Health came before the Court
from a granting of a motion to dismiss on the pleadings, the Court had to as-
sume the truth of the material facts as alleged in the complaint. Summit Health,
111 S. Ct. at 1845. For a complete discussion of the standard of review from a
motion to dismiss on the pleadings, see infra note 86 and accompanying text.
70. Id. at 1845 & n.4. Midway, located in Los Angeles, is owned and oper-
ated by Summit Health, which owns and operates 19 other hospitals and 49
health care facilities in seven states and Saudi Arabia. Id. at 1846. As a member
of Midway's medical staff, Dr. Pinhas had the right to admit his patients to the
defendant-hospital and to use the hospital's facilities for the care and treatment
of his patients. Plaintiff's First Amended Complaint at 21, Summit Health,
Ltd. v. Pinhas, 111 S. Ct. 1842 (1991) (No. 89-1679), reprinted in 24 Trade Reg.
Series A-36, A-42 (No. 1, 1990-1991) [hereinafter Amended Complaint].
Pinhas and the defendants were involved in interstate commerce because both
parties served out-of-state patients and received Medicare reimbursement pay-
ments from out-of-state. Summit Health, 111 S. Ct. at 1846.
71. Summit Health, 111 S. Ct. at 1845; see Amended Complaint at 44 21-22.
Because of the speed and precision with which he, as compared to his competi-
tors, performed these procedures, Dr. Pinhas had a high level of success and
few, if any, complications. Summit Health, 111 S. Ct. at 1845 n.3; see Amended
Complaint at 22. The amount of time taken to complete one of the proce-
dures is crucial to its success because it reduces the exposure of the cut eye
tissue. Summit Health, 111 S. Ct. at 1845 n.3; see Amended Complaint at 22.
Dr. Pinhas estimated that his competitors regularly took, on average, six times as
long to complete the same procedures as Dr. Pinhas. Summit Health, 111 S. Ct. at
1845 n.3; see Amended Complaint at 22.
72. Summit Health, 111 S. Ct. at 1845; see Amended Complaint at 23.
73. Summit Health, 111 S. Ct. at 1845; see Amended Complaint at 23.
74. Summit Health, 111 S. Ct. at 1845; see Amended Complaint at 24. Dr.
Pinhas and certain other ophthalmic surgeons at Midway requested that Midway
modify its assistant surgeon requirement. Summit Health, 111 S. Ct. at 1845; see
Amended Complaint at T 25. The request was subsequently denied. Summit
Health, 111 S. Ct. at 1845; see Amended Complaint at T 25.
Midway's refusal to abandon the assistant physician requirement meant that
surgeons, like Dr. Pinhas, who were able to perform procedures alone, were
forced to compensate their competitors to act as assistants during surgery. Sum-
[Vol. 37: p. 373
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ern California hospitals complied with Medicare's new policy, Midway
and Cedars-Sinai Medical Center, whose medical staffs overlap, refused
to eliminate their assistant physician requirement. 75
On or about January 26, 1987, Midway tried to induce Dr. Pinhas
into signing a "sham" contract in order to reimburse his additional ex-
pense of complying with its assistant physician requirement. 76 The con-
tract purported to hire Dr. Pinhas for $36,000 per year (later raised
orally to $60,000) for special services that he would not be required to
perform. 7 7 Dr. Pinhas refused to sign or return the "sham" contract,
even though the Chief of Staff of Midway threatened Dr. Pinhas with
peer review proceedings. 78
On April 13, 1987, Dr. Pinhas was notified by letter from Summit
Health and Midway that he was summarily suspended as of that date and
that he would be subject to peer review proceedings. 79 As a result of
these proceedings, Dr. Pinhas was eventually terminated, losing his
medical staff privileges.8 0
In response to his termination, Dr. Pinhas brought suit.8 1 Dr.
mit Health, 111 S. Ct. at 1845; see Amended Complaint at 26. Dr. Pinhas noti-
fied Midway that the hospital's policy would cost him an additional $60,000 per
year. Summit Health, 111 S. Ct. at 1845; see Amended Complaint at 26. Dr.
Pinhas expressed his desire to remain at Midway but stated that he would move
his practice if the assistant physician requirement was not abolished. Summit
Health, 111 S. Ct. at 1845; see Amended Complaint at 1 26.
75. Summit Health, 111 S. Ct. at 1845; see Amended Complaint at 25.
76. Summit Health, 111 S. Ct. at 1845; see Amended Complaint at 27.
77. Summit Health, 111 S. Ct. at 1845; see Amended Complaint at 27. Dr.
Pinhas was told that numerous members of Midway's medical staff had similar
contracts. Id.
78. Amended Complaint at 28. After Dr. Pinhas' refusal, Midway made
one monthly $5,000 payment to him that was "buried" in a reimbursement
check. Id. at 28. Dr. Pinhas recorded this amount as an overpayment and a
credit to the amount that Midway otherwise owed him. Id.
79. Summit Health, 111 S. Ct. at 1845 & n.4; see Amended Complaint at 29.
80. Summit Health, 111 S. Ct. at 1845; see Amended Complaint at $ 32. The
peer review proceedings allegedly considered questions regarding the "appro-
priateness of surgical procedures in light of patient's medical condition; ade-
quacy of documentation in medical records; and an ongoing pattern of identified
problems." Summit Health, 111 S. Ct. at 1845 n.4. (quoting Amended Complaint
at 29).
Dr. Pinhas' first hearing was before Midway's Executive Committee, which
upheld his summary suspension with the recommendation that his staff privi-
leges at Midway be terminated. d. at 1845; see Amended Complaint at 1 32. Dr.
Pinhas appealed this decision to Midway's Judicial Review Committee, which on
June 29, 1987, upheld the decision of the Executive Committee. Summit Health,
111 S. Ct. at 1845; see Amended Complaint at 32-33.
Summit Health and Midway were also preparing to distribute the adverse
peer review report about Dr. Pinhas to other health care facilities. Summit Health,
111 S. Ct. at 1845. Summit Health and Midway had already distributed the re-
port to Cedars-Sinai Medical Center in Los Angeles. Id. at 1845 n.6. Pinhas was
subsequently denied staff privileges at Cedars-Sinai. Id.
81. In his amended complaint, Dr. Pinhas named as defendants Summit
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Pinhas alleged, among other charges, that Summit Health and Midway
violated section 1 of the Sherman Act through its conspiracy to exclude
Dr. Pinhas from the Los Angeles ophthalmological services market.82
The United States District Court for the Central District of Califor-
nia granted Summit Health's 12(b)(6)8 3 motion to dismiss Dr. Pinhas'
Amended Complaint without leave to amend.8 4 Dr. Pinhas appealed the
dismissal of several of his claims to the United States Court of Appeals
for the Ninth Circuit.8 5 The Ninth Circuit reversed the dismissal of Dr.
Pinhas' antitrust claim and affirmed both the dismissal of the § 1983
claim and the request for declaratory judgment.86
The Ninth Circuit, in reversing the dismissal of Dr. Pinhas' antitrust
claim, held that in order to invoke the jurisdiction of the Act, Dr. Pinhas
had to "identify a relevant aspect of interstate commerce and then show
,as a matter of practical economics' that the Hospital's activities have a
'not insubstantial effect on the interstate commerce involved.' "87 The
court was satisfied that Dr. Pinhas' complaint proved that the peer re-
Health, the parent company of Midway Hospital; Midway Hospital; the medical
staff of Midway; nine individuals involved in the peer review proceedings; Weiss-
burg & Aronson, Inc., Summit Health's law firm; and the State of California,
Board of Medical Quality Assurance, among others. Amended Complaint at 4
6-19.
82. Dr. Pinhas' first claim of relief was a request for declaratory relief
against Summit Health. Id. at TT 79-108. The second and third claims for relief
were for damages for violations of Dr. Pinhas' constitutional rights and the Civil
Rights Act, 42 U.S.C.A. §§ 1983, 1985(3) (West 1991). Id. at 4 109-19. Dr.
Pinhas' fourth claim for relief was for treble damages for violation of the Act. Id.
at $T 120-26. In the fourth claim, Dr. Pinhas alleged that Summit Health and its
medical staff entered into a combination and conspiracy to boycott and drive Dr.
Pinhas out of business in order to secure for the defendant-physicians a greater
share of the ophthalmic surgery market in Los Angeles. Id. at 124. In his fifth
claim, Dr. Pinhas asked for injunctive relief against all defendants. Id. at $T 127-
29.
83. FED. R. Civ. P. 12(b)(6).
84. Pinhas v. Summit Health, Ltd., 894 F.2d 1024, 1024 (9th Cir. 1990),
aff'd, 111 S. Ct. 1842 (1991).
85. Id. at 1025.
86. Id. at 1026. In reviewing the district court's dismissal of Dr. Pinhas'
amended complaint for failure to state a claim, the Ninth Circuit reviewed the
lower court's ruling de novo. Id. at 1028. The Ninth Circuit restricted its review
to the contents of Dr. Pinhas' Amended Complaint. Id.; see Fort Vancouver Ply-
wood Co. v. United States, 747 F.2d 547, 552 (9th Cir. 1984). The Ninth Cir-
cuit, in reviewing the district court's dismissal of the complaint, stated that a
"complaint should not be dismissed... 'unless it appears beyond doubt that the
plaintiff can prove no set of facts in support of his claim which would entitle him
to relief.' " Pinhas, 894 F.2d at 1028 (quoting Conley v. Gibson, 355 U.S. 41,45-
46 (1957)).
87. Pinhas, 894 F.2d at 1031-32 (citing Mitchell v. Frank R. Howard Memo-
rial Hosp., 853 F.2d 762, 764 (9th Cir. 1988)). This holding appears to reaffirm
the Ninth Circuit's adoption of the minority interpretation of McLain that juris-
diction under the Act is met if the general business activities of the defendant
have a substantial impact on interstate commerce. For a further discussion of
the minority interpretation of McLain, see supra note 68 and accompanying text.
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view process at Summit Health substantially affected interstate com-
merce, since the process impacted the entire staff at the hospital. 8 8
Specifically, the court relied on Dr. Pinhas' allegations that Summit
Health and Midway illegally conspired to prevent him from providing
his patients "with lower prices as a result of his ability to perform opera-
tions at a rate quicker than that of his competitors. ' 8 9 As a result, the
court found that Dr. Pinhas alleged facts sufficient to show that Summit
Health's "activities" had a substantial effect on interstate commerce. 90
Summit Health filed a petition for writ of certiorari to the United
States Supreme Court to review the Ninth Circuit's decision on Dr.
Pinhas' antitrust claim, claiming that Dr. Pinhas' amended complaint did
not meet the jurisdictional requirements of the Act, as enunciated in
McLain.9 Specifically, Summit Health maintained that Dr. Pinhas had
failed to prove a "factual nexus between the alleged boycott and inter-
state commerce." 9 2 The Court granted certiorari to consider Summit
Health's assertion. 9 3 The issue as framed in Summit Health provided an
opportunity for the Court to resolve the split in the circuits concerning
the jurisdictional aspect of interstate commerce under the Act.9 4 That
aspect was whether defendants' alleged illegal activity in conspiring to
exclude Dr. Pinhas from the practice of ophthalmic surgery in Los Ange-
les had a nexus with interstate commerce sufficient enough for the Act's
88. Pinhas, 894 F.2d at 1032. The court stated that Dr. Pinhas did not need
to make "the more particularized showing of the effect on interstate commerce
caused by the alleged conspiracy to keep him from working." Id.
The Ninth Circuit also held that the state action doctrine did not provide a
peer review board with immunity from an antitrust action. Id. at 1028-30. In
construing the Supreme Court's decision in Patrick v. Burget, the Ninth Circuit
applied the rigorous two-prong test of California Retail Liquor Dealers Association v.
MidcalAluminum, Inc. Pinhas, 894 F.2d at 1028 (citing Patrick v. Burget, 486 U.S.
94 (1988) and California Retail Liquor Dealers Ass'n v. Midcal Aluminum, Inc.,
445 U.S. 97 (1980)). The Midcal test requires that the alleged restraint must be
"one clearly articulated and affirmatively expressed as state policy" and "the
[alleged] conduct must be actively supervised by the State itself." Id. at 1029
(quoting Patrick, 486 U.S. at 100 (quoting Midcal, 445 U.S. at 105)).
89. Pinhas, 894 F.2d at 1032.
90. Id. at 1031-32. The Ninth Circuit's decision in Pinhas supports the mi-
nority interpretation of McLain eliminating the necessity of proving a nexus be-
tween the alleged illegal restraint and its effect on interstate commerce. For an
analysis of the split between the circuits on this issue, see supra notes 66-68 and
accompanying text.
91. Summit Health, 111 S. Ct. at 1844-45. In its petition, Summit Health
argued that there was a clear conflict among the circuits as to the jurisdictional
requirements of the Act. Petition for a Writ of Certiorari at 3-4, Summit Health,
Ltd. v. Pinhas, 110 S. Ct. 3212 (1990) (No. 89-1679) (granting certiorari), re-
printed in 24 Trade Reg. Series 8 (No. 1, 1990-1991).
92. Summit Health, 111 S. Ct. at 1845.
93. Id. at 1844.
94. For a discussion of the split in the circuits following McLain, see supra
notes 66-68 and accompanying text.
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jurisdiction to attach. 95
B. Justice Stevens' Majority Opinion
Prior to reaching a decision as to whether Dr. Pinhas' allegations
were sufficient to meet the interstate commerce requirements under the
Act, the Court stated several undisputed propositions.9 6 First, the
Court concluded that Summit Health was "unquestionably engaged in
interstate commerce."'9 7 The Court further stated that Midway,
although primarily providing health care services in a local market, was
involved in interstate commerce.98
In response to the Court's reasoning, Summit Health and Midway
contended that the restraint's exclusion of one physician from a market
had no factual nexus with interstate commerce.9 9 However, the Court
concluded that Dr. Pinhas' allegations were sufficient to implicate inter-
95. Summit Health, 111 S. Ct. at 1844.
96. Id. at 1847. The majority opinion of the Court was delivered by Justice
Stevens, in which Chief Justice Rehnquist and Justices White, Marshall and
Blackmun joined. Justice Scalia filed a dissenting opinion, in which Justices
O'Connor, Kennedy and Souter joined. For a further discussion of Justice
Scalia's dissenting opinion, see infra notes 113-22 and accompanying text. For a
further discussion of the procedural aspects of this appeal, see supra notes 83-95
and accompanying text.
97. Summit Health, Ill S. Ct. at 1847. The Court based this conclusion on
the facts alleged in Dr. Pinhas' Amended Complaint, indicating that Summit
Health owned and operated 19 hospitals and 49 other health care facilities in
seven states and Saudi Arabia. Id. at 1846; see Amended Complaint at 6.
98. Summit Health, 111 S. Ct. at 1847. In adopting this proposition, the
Court posited, hypothetically, that the Act would cover any conspiracy that at-
tempted to exclude Midway from a relevant health services market, even though
the actual effect, if any, on interstate commerce would be "indirect." Id. The
Summit Health Court also noted that peer review reports are regularly distributed
to out-of-state hospitals and affect a doctor's employment opportunities in other
states. Id. at 1846.
The Court cited Hospital Building Co. v. Trustees of Rex Hospital, as support for
the conclusion that the interstate nexus required under § 1 of the Act is estab-
lished by the fact that Midway's services are "regularly performed for out-of-
state patients and generate revenues from out-of-state sources." Id. at 1847 (cit-
ing Hospital Bldg. Co. v. Trustees of Rex Hosp., 425 U.S. 738 (1976)). The
Summit Health Court stated that "[n]o specific purpose to restrain interstate com-
merce is required." Id. For a further discussion of Hospital Building, see supra
note 60 and accompanying text.
The Summit Health Court posited that Midway's "provision of ophthalmolog-
ical services affects interstate commerce because both physicians and hospitals
serve nonresident patients and receive reimbursements through Medicare pay-
ments." Summit Health, 111 S. Ct. at 1846. There was no allegation in Dr.
Pinhas' Amended Complaint or in the briefs submitted to the Court that Summit
Health or Midway serviced out-of-state patients, or received payment from out-
of-state sources. Apparently, the Court drew these conclusions sua sponte.
99. Summit Health, 111 S. Ct. at 1847. Petitioners contended that Dr.
Pinhas' complaint did not deny the fact that there was an "adequate supply" of
other physicians to perform the same services for all of Dr. Pinhas' current and
future patients. Id.
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state commerce. 0 0 In reaching its conclusion, the Court addressed two
fatal errors made by both Summit Health and Midway in arguing that
the exclusion of Dr. Pinhas did not sufficiently impact interstate
commerce.
First, the Court concluded that Summit Health incorrectly argued
that Dr. Pinhas was required to allege, under McLain, that the conspiracy
to exclude him had an actual effect on interstate commerce in order to
obtain federal jurisdiction under the Act.' 0 The Court held, however,
that the crux of a violation of section 1 of the Act is the illegal agreement
itself, not the "overt acts performed in furtherance of it. '1 0 2 According
to the Court, an analysis under section 1 of the Act should focus on "the
potential harm that would ensue if the conspiracy were successful,"
rather than on the actual effects.' 0 3 One potential harm of Summit
Health's offending activity mentioned by the Court was a general reduc-
tion in available ophthalmological services in the Los Angeles area.' 0 4
Therefore, the Court concluded that Dr. Pinhas did not need to allege,
or evidence, an actual effect on interstate commerce in order to obtain
jurisdiction under the Act. ' 0 5
A second error the Court found in Summit Health's argument was
that Summit Health mistakenly analyzed the competitive significance of
Dr. Pinhas' exclusion from the ophthalmological market based only
upon a "particularized evaluation of his own practice."' 1 6 Instead, the
Court focused on the broader effects of a successful conspiracy and con-
cluded that "as a matter of practical economics" the ophthalmological
services market in Los Angeles would be reduced by Dr. Pinhas' exclu-
100. Id. at 1848-49.
101. Id. at 1847-48. The Court in McLain held that "under the Sherman
Act, liability may be established by proof of either an unlawful purpose or an
anticompetitive effect." McLain v. Real Estate Bd., Inc., 444 U.S. 232, 243
(1980) (citing United States v. United States Gypsum Co., 438 U.S. 422, 436 n.
13 (1978)). The McLain Court posited that, otherwise, if obtaining jurisdiction
required a demonstration that the alleged activity itself had an actual impact on
interstate commerce, jurisdiction could easily be defeated by a showing that "the
alleged restraint failed to have its intended anticompetitive effect." Id.
102. Summit Health, 111 S. Ct. at 1847.
103. Id.
104. Id. at 1848.
105. Id.
106. Id. The Court significantly expanded the scope of the Act's jurisdic-
tional reach by holding that not only must the analysis address the restraint's
impact on Dr. Pinhas' own practice, but that it must also address the restraint's
potential impact on other hospitals, doctors, patients and participants and po-
tential participants in the Los Angeles ophthalmological services market. Id.
The Court's new standard is not supported by references to any of the volumi-
nous precedent on the subject of jurisdiction handed down by the Court. This
new test is a significant expansion of even the broadest of the jurisdictional tests
adopted by the circuit courts or identified by commentators. For a discussion of
the identified tests, see infra notes 127-37 and accompanying text.
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sion. 10 7 Thus, according to the Court, this reduction in ophthalmologi-
cal services provided a sufficient nexus with interstate commerce to
support jurisdiction under the Act. 10 8
In applying McLain to the holding that the reduction of ophthalmo-
logical services impacted interstate commerce, the Summit Health Court
quoted extensively from the McLain opinion, but, ultimately, the Court
did not adopt the language of the McLain Court.' 0 9 The McLain Court
107. Summit Health, 111 S. Ct. at 1848 (quoting McLain, 444 U.S. at 246).
The Court did, however, state that the case involved not only an alleged re-
straint on Dr. Pinhas' access to the practice of ophthalmology at Midway by Mid-
way and its medical staff, but also an alleged restraint on Dr. Pinhas' access to
the practice of ophthalmology at Midway and other area hospitals through Sum-
mit Health's alleged misuse of the federally regulated peer review process and
adherence to "an unnecessarily costly procedure." Id. For a further discussion
of the Health Care Quality Improvement Act of 1986, which is federal legislation
regulating peer review boards and granting them limited immunity from anti-
trust violations, see infra notes 166-71 and accompanying text.
108. Summit Health, 111 S. Ct. at 1848-49. As support for this conclusion,
the Court cited cases involving illegal agreements allocating territories and fix-
ing prices within a single state. The Court held in Burke v. Ford that an agree-
ment to divide a liquor distribution market within a single state "almost surely"
had a market-wide impact, thus affecting interstate commerce. Id. (quoting
Burke v. Ford, 389 U.S. 320, 322 (1967)). The plaintiffs in Burke, Oklahoma
liquor retailers, sued under § 1 of the Act to enjoin an "alleged state-wide mar-
ket division by all Oklahoma liquor wholesalers." Burke, 389 U.S. at 320. The
Court noted that Oklahoma had no in-state liquor distilleries, which meant that
liquor is shipped to Oklahoma wholesalers from out-of-state distilleries. Id. at
321. The Court stated that "[h]orizontal territorial divisions almost invariably
reduce competition among the participants." Id. The market division reduced
competition, which in turn raised prices and lowered unit sales. Id. at 322. The
Court held that the market division "almost surely resulted in fewer sales to
retailers-hence fewer purchases from out-of-state distillers-than would have
occurred had free competition prevailed among the wholesalers." Id. This case
demonstrated the Court's willingness to find an impact on interstate commerce
when the alleged restraint is apparently only an intrastate activity.
Similarly, in McLain, the Court held that the real estate brokers' price-fixing
conspiracy " 'necessarily affect[ed]' the volume of residential [home] sales and
therefore the demand for financing and title insurance provided by out-of-state
concerns." Summit Health, 111 S. Ct. at 1848 (quoting McLain, 444 U.S. at 246).
In McLain, the Court held that jurisdiction is established by a demonstration of a
"substantial effect on interstate commerce generated by [the real estate] broker-
age activity." McLain, 444 U.S. at 242. The Court further stated that "the more
particularized showing of an effect on interstate commerce caused by the alleged
conspiracy to fix commission rates, or by those other aspects of [the brokers']
activity that are alleged to be unlawful, need not be made." Id. For a further
discussion of McLain, see supra notes 56-65 and accompanying text.
In Summit Health, the Court stated that the same analysis used in McLain
applied to the facts of the instant case, even though the McLain plaintiffs were
consumers of the conspirator's brokerage services, Dr. Pinhas was a competitor
of the conspirators, and Dr. Pinhas identified himself in his complaint as the sole
victim of the alleged conspiracy. Summit Health, 111 S. Ct. at 1848. The Court
held that the same analysis applied because a violation of the Act is far more
significant than the conspiracy's effect on a single plaintiff. Id.
109. Id. at 1850 (Scalia, J., dissenting). The Summit Health majority rejected
the two previously competing interpretations of McLain. Id. (Scalia, J., dissent-
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held that jurisdiction under the Act was available upon a showing that
the alleged "infected" activities be shown, "as a matter of practical eco-
nomics," to have a substantial effect on interstate commerce."l 0 The
impact of the alleged restraint on other participants and its potential
harm in the relevant market from which plaintiff was excluded was not
addressed in McLain. The McLain Court did not demand that plaintiffs
speculate on potential harm to potential participants in the relevant
market in order to gain federal jurisdiction.
Instead of adopting the language of McLain, the Summit Health ma-
jority focused upon the "competitive significance" of Dr. Pinhas' exclu-
sion from the relevant market. Under the Act, the Summit Health Court
held that the jurisdictional issue must be evaluated on the basis of the
restraint's effect "on other participants and potential participants in the
[relevant] market."' 1 I The Court concluded that the alleged conspir-
acy, which excluded Dr. Pinhas from the Los Angeles ophthalmological
services market, had a sufficient nexus with interstate commerce to sup-
port federal jurisdiction under the Act." 12
C. Justice Scalia's Dissenting Opinion
Four members of the Court disagreed with the majority's creation
of a new interpretation of the McLain jurisdiction standard. Justice
Scalia argued for the dissent that the correct jurisdictional test should
examine whether the illegal conspiracy actually has a substantial effect on
interstate commerce by restricting interstate commerce, or by interrupt-
ing its "flow," rather than assessing its impact on potential participants
in the market. 13 Instead of settling the jurisdictional split, Justice
Scalia complained that the majority's approach to the jurisdictional test
"compounds the confusion by rejecting the two competing interpreta-
tions of McLain and adding yet a third candidate to the field, one that no
court or commentator has ever suggested, let alone endorsed." 114
As an alternative test, Justice Scalia suggested that the jurisdictional
issue should be decided by applying the pre-McLain jurisdictional stan-
dard.1 5 Justice Scalia cited the Court's holding in United States v. Oregon
ing). For a discussion of the competing interpretations of McLain, see supra
notes 66-68 & infra notes 127-37 and accompanying text.
110. McLain, 444 U.S. at 246 (quoting Hospital Bldg. Co. v. Trustees of
Rex Hosp., 425 U.S. 738, 745 (1976)). For a further discussion of the Court's
holding in McLain, see supra notes 56-65 and accompanying text.
111. Summit Health, 111 S. Ct. at 1848.
112. Id. at 1848-49.
113. Id. at 1851 (ScaliaJ., dissenting). Justice Scalia was joined in dissent
by Justices O'Connor, Kennedy and Souter.
114. Id. at 1850 (Scalia, J., dissenting). Justice Scalia complained that the
majority's approach completely ignored the substantiality of the alleged re-
straint's impact on interstate commerce. Id. (Scalia, J., dissenting).
115. Id. at 1853 (Scalia, J., dissenting) (recommending re-application of
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State Medical Society 116 to illustrate such a "workable jurisdictional
test."' 7 Justice Scalia recommended applying the stricter pre-McLain
test in order to prevent easy access to the federal forum, where treble
damages are possible." 18
Furthermore, Justice Scalia argued that a vital part of antitrust anal-
ysis is defining the "market" for the goods or services in question." t 9
Justice Scalia argued that Dr. Pinhas never alleged that the restraint was
aimed at the entire Los Angeles ophthalmological market. 120 Instead,
Dr. Pinhas only alleged that Summit Health and Midway conspired to
exclude him from the market by effecting "a sort of group boycott,"
workable jurisdictional approach established before the Court's holding in Mc-
Lain confused issue).
116. 343 U.S. 326 (1952).
117. Summit Health, Il1 S. Ct. at 1853 (Scalia, J., dissenting). In Oregon Med-
ical Society, the United States alleged that the Oregon State Medical Society, eight
county medical societies, a doctor-sponsored corporation engaged in the sale of
prepaid medical services, and eight doctors violated § 1 of the Act through their
conspiracy to monopolize the provision of prepaid medical services in Oregon.
Oregon Medical Soc'y, 343 U.S. at 328. The conspiracy was successful because the
corporation that sold prepaid medical services entered into an agreement not to
sell such services in the territory covered by eight county medical societies. Id.
The Court was asked to decide whether the business of providing prepaid medi-
cal services was interstate commerce. Id. at 331-32. The Court held that in or-
der for the government to prove a nexus with interstate commerce, the
government must demonstrate that the restraint had a substantially detrimental
impact on interstate commerce. Id. at 338-39. In adopting the test set forth in
Oregon Medical Society, Justice Scalia concluded that the district court was correct
in dismissing Dr. Pinhas' amended complaint. Summit Health, 111 S. Ct. at 1853
(Scalia, J., dissenting).
118. Summit Health, 111 S. Ct. at 1854 (Scalia, J., dissenting). Justice Scalia
stated that "[d]isputes over the denial of hospital practice privileges are com-
mon, and most of the circuits to which they have been presented . . . have re-
jected them on jurisdictional grounds." Id. (Scalia, J., dissenting). Justice Scalia
did not believe that federal jurisdiction was warranted because Dr. Pinhas simply
alleged he and the defendants were both involved in interstate commerce, but
gave no specific evidence of the level of interstate commerce involvement. Id. at
1853 (Scalia, J., dissenting); see Amended Complaint at 5-10. Justice Scalia
found no allegations of the treatment of any out-of-state patients. Summit Health,
111 S. Ct. at 1853 (Scalia,J., dissenting). Furthermore, Justice Scalia found that,
even if there were a substantial number of out-of-state patients, there was no
evidence that if Summit Health and Midway's second physician requirement re-
sulted in an overcharging of Medicare that this requirement would substantially
effect interstate commerce. Id. (Scalia, J., dissenting). Justice Scalia also found
no allegations of out-of-state insurance payments for the overcharges or the use
of out-of-state suppliers by the hospital. Id. (Scalia,J., dissenting). Justice Scalia
argued that Dr. Pinhas may have had a valid business tort claim arising from
negligent peer review, but this claim would not fall within the scope of the Act.
Id. at 1853-54 (Scalia,J., dissenting) (citing for comparison Hayden v. Bracy, 744
F.2d 1338, 1343-45 (8th Cir. 1984)).
119. Summit Health, 111 S. Ct. at 1850-51 (Scalia, J., dissenting). By "mar-
ket," Justice Scalia meant "the scope of other products or services against which
[the goods or services in question] must compete." Id. (Scalia, J., dissenting).
120. Id. at 1851 (Scalia, J., dissenting).
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which is a per se violation of the Act. 12 In noting that there was no
allegation made that Midway's conspiracy affected the peer review pro-
ceedings at other Los Angeles hospitals, Justice Scalia stated that, con-
comitantly, there was no justification for the majority's assumption that
the alleged conspiracy affected the entire Los Angeles market.' 2 2
IV. THE NEWEST EXPANSION OF THE ACT'S INTERSTATE COMMERCE
JURISDICTIONAL SCOPE
The Court's decision in Summit Health is remarkable in several ways.
First, the Court failed to resolve the split in the circuits over the issue of
the Act's interstate commerce jurisdictional scope. 123 Rather, the
Court's majority opinion formulated a unique interpretation and expan-
sion of the McLain Court's jurisdictional standard, which does not clarify
the jurisdictional standard under section 1 of the Act. Second, the ma-
jority's broad interpretation of the McLain test appears to remove alto-
gether any jurisdictional obstacle to private plaintiffs suing under the
Act. Finally, the expansion of the jurisdictional test will create a result
which seems to run counter to the intent of other federal legislation. 12 4
A. A New Expansion of the McLain Tests
As noted previously, Summit Health provided the Court with an op-
portunity to resolve the split in the circuits regarding the scope of the
interstate commerce jurisdiction test of the Act.12 5 However, the Summit
Health Court did not specifically address the circuit court split regarding
the competing interpretations of McLain, and accordingly, the Court did
not resolve the conflict among the circuits.1 2 6 Therefore, following
121. Id. (Scalia, J., dissenting). "Group boycotts, or concerted refusals by
traders to deal with other traders, have long been held to be [I forbidden ......
Klor's, Inc. v. Broadway-Hale Stores, Inc., 359 U.S. 207, 212 (1959). The com-
mon understanding of a per se violation in antitrust law is that it implies that
certain types of business arrangements, such as price-fixing, are considered in-
herently anti-competitive and injurious to the public without any need to deter-
mine if the agreement injured market competition. BLACK'S LAW DICTIONARY
1142 (6th ed. 1990).
122. Summit Health, 111 S. Ct. at 1852 (Scalia, J., dissenting). Justice Scalia
stated that these facts prove the "truly local nature of the restraint" and contra-
vene the holding that the conspiracy affected competition in the Los Angeles
market. Id.
123. For a further discussion of the split in the circuits, see supra notes 66-
68 and accompanying text.
124. Specifically, the Health Care Quality Improvement Act (HCQIA) of
1986, intended to promote effective peer review, provides peer review boards
with a potential defense to antitrust claims from physicians denied staff privi-
leges. 42 U.S.C.A. §§ 11101-52 (West Supp. 1992). For a complete discussion
of the HCQIA, see supra notes 166-71 and accompanying text.
125. For a complete discussion of Summit Health, see supra notes 69-122 and
accompanying text.
126. Summit Health, 111 S. Ct. at 1850 (Scalia, J,, dissenting). Justice Scalia
addressed the split by stating that "the Court could have cleared up the confu-
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Summit Health, there are arguably four distinct jurisdictional tests under
the Act.
Although the circuit split has produced only two competing inter-
pretations of the McLain test, commentators have isolated three distinct
jurisdictional tests applied by various courts when interpreting the
Court's holding in McLain. 12 7
The first test which courts have extracted from McLain is character-
ized by commentators as the "general business activities" test. 128
Under this expansive test, jurisdiction is granted if the defendant's gen-
eral business activities have a substantial effect on interstate com-
merce. 129 This is essentially the test adopted by the minority of the
sion created by McLain .... Instead, it compounds the confusion by rejecting
the two competing interpretations of McLain and adding yet a third candidate to
the field, one that no court or commentator has ever suggested, let alone en-
dorsed." Id. (Scalia, J., dissenting).
127. For a discussion of the first test, the "general business activities" test,
see infra notes 128-32 and accompanying text. For a discussion of the second
test, the "infected activities" test, see infra notes 133-35 and accompanying text.
For a discussion of the third test, the particularized wrongful conduct test, see
infra notes 136-37 and accompanying text.
128. Comment, supra note 5, at 132. This commentator stated that compel-
ling language in McLain seemingly requires only that the defendant's "general
business activities," not the allegedly illegal activity, must have a substantial im-
pact on interstate commerce. Id. The Ninth Circuit's decision in Western Waste
provides a fine example of the application of this standard. Western Waste Serv.
Sys. v. Universal Waste Control, 616 F.2d 1094, 1096-99 (9th Cir.), cert. denied,
449 U.S. 869 (1980). Western Waste involved two competing Arizona distributors
of garbage compactors manufactured by out-of-state companies. Id. at 1096.
Western Waste was the dealer of Blackwelder, a California manufacturer of com-
pactors. Id. Universal induced Blackwelder to terminate its distributorship with
Western Waste and to select Universal as its exclusive distributor in Phoenix. Id.
Universal began advertising itself as the exclusive distributor of Blackwelder
compactors in the Phoenix market. Id. In applying McLain, the Western Waste
court held that federal jurisdiction under the Act attached if Universal's rubbish
collection business substantially affected interstate commerce. Id. at 1097. As
evidence of its effects on interstate commerce, the court found that Universal
spent $69,680 in 1975 and $356,061 in 1976 for equipment purchased from out-
of-state sellers, while Western Waste spent $88,355 and $124,007 in the respec-
tive years. Id. at 1098; see generally Richard A. Mann, The Applicability of Antitrust
Law to Activities of Real Estate Boards: Before and After McLain, 18 Hous. L. REV.
317, 334-35 (1981) (general business activities test views nearly all business ac-
tivity of defendant as satisfying jurisdictional test of Act); Mann, supra note 6, at
866 ("expansive interpretation" of McLain holds that defendant's "general busi-
ness activities" must have substantial impact on interstate commerce); Brief for
Respondent at 10, Summit Health (No. 89-1679), reprinted in 24 Trade Reg. Series
133, 149 (No. 1, 1990-1991) (if defendant's "general business activities" have
substantial effect on interstate commerce, then federal jurisdiction under Act is
available).
129. Comment, supra note 5, at 132. This expansive test is in line with the
broad regulatory powers given to Congress by the Commerce Clause of the
Constitution. Id. at 133-34. For a further discussion of the broad power given
by the Commerce Clause, see supra note 1 and accompanying text.
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circuits that have addressed this precise issue.1 30 As applied to the facts
of Summit Health, jurisdiction under the Act would appear to attach if the
"aggregation of all hospital staff activities substantially affects interstate
commerce."' 3 1 General adoption of this test would effectively abolish
the interstate commerce jurisdictional test of the Act, because the total
aggregation of any defendant's business activities are likely to somehow
affect interstate commerce. 13 2
The second test adopted by courts and identified by commentators
presents a somewhat narrower interpretation of McLain and is referred
to as the "infected activities" test.' 3 3 This test appears to be based
upon a literal interpretation of the McLain holding that defendants' ac-
tivities that have been infected by the alleged restraint must be shown to
have a substantial impact on interstate commerce.1 34 Under the facts
presented in Summit Health, a showing that the general activities of the
peer review board substantially affected interstate commerce appears to
be necessary in order for jurisdiction under the Act to attach under the
"infected activities" test.' 3 5
130. For a further discussion of the interpretation of McLain by a minority
of the circuits, see supra note 68 and accompanying text.
131. Comment, supra note 5, at 134. Thus, for Dr. Pinhas to obtain federal
jurisdiction under the Act, he would need to demonstrate that the normal oper-
ating activities of Summit Health and Midway affect interstate commerce. Such
effect could be shown by the purchase of supplies and equipment from out-of-
state suppliers. Also, the treatment of out-of-state patients, and the receipt of
reimbursement for services from out-of-state insurance companies or other
sources would also likely evidence the requisite interstate effect.
132. Philip C. Kissam et al., Antitrust and Hospital Privileges: Testing the Con-
ventional Wisdom, 70 CAL. L. REV. 595, 632-33 (1982). This language in McLain
appears to be simple dicta that has been taken out of context by courts and
commentators. Id. The offending language in McLain states that it would be
sufficient for a plaintiff to "demonstrate a substantial effect on interstate com-
merce generated by [defendants'] brokerage activity." McLain, 444 U.S. at 243.
Later in the opinion, the Court also stated that one element of a successful cause
of action under the Act requires that there be a demonstrable nexus between
"the defendant's activity and interstate commerce." Id. at 246.
133. Kissam et al., supra note 132, at 632. The authors contend that a lit-
eral reading of the McLain opinion demonstrates that the Court held that the
"infected activities" of New Orleans real estate brokers had an effect on inter-
state commerce sufficient to establish jurisdiction under the Act. Id. (citing Mc-
Lain, 444 U.S. at 242, 246).
A minority of the circuit courts have adopted the "general business activi-
ties" test instead of this narrower interpretation of McLain. Kissam et al., supra
note 132, at 632-33. This confusion over the precise holding of the McLain
Court stems from the fact that the McLain opinion contains language that ap-
pears to adopt the "general business activities" test. For a discussion of the
conflicting language in McLain that refers to the "general business activities"
test, see supra notes 128-32 and accompanying text. For a discussion of the in-
terpretation of McLain by a minority of the circuit courts, see supra note 68 and
accompanying text.
134. McLain, 444 U.S. at 246 (citing Hospital Bldg. Co. v. Trustees of Rex
Hosp., 425 U.S. 738, 745 (1976)).
135. Most likely, Dr. Pinhas would need to show that actions of the peer
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The third and narrowest interpretation of the McLain test employed
by the circuits is referred to as the "particular wrongful conduct"
test. 136 Under this test, jurisdiction would be granted if the allegedly
illegal conduct or restraint, as identified by the plaintiff, has a substantial
effect on interstate commerce. 137 As applied to the facts of Summit
Health, Dr. Pinhas would have to show that the exclusionary and conspir-
atorial conduct of the peer review board had a substantial effect on in-
terstate commerce in order to invoke jurisdiction under the "particular
wrongful conduct" test.
These conflicting interpretations were evidenced in the arguments
of Summit Health and Dr. Pinhas before the Court. In promoting the
use of the "particular wrongful conduct" test, Summit Health con-
tended that the exclusion of a single physician from the Los Angeles
ophthalmological market had no substantial effect on interstate com-
merce. 138 Conversely, Dr. Pinhas argued, in advocating the affirmance
of the Ninth Circuit's opinion, that the Ninth Circuit correctly adopted
the "infected activities" test. 139
Instead of addressing these conflicting interpretations of the Mc-
Lain opinion, the Court focused, not upon the actual effect of the alleg-
edly illegal restraint, "but rather upon the potential harm that would
ensue if the conspiracy were successful."140 This addition of "potential
harm" into the jurisdictional equation not only does not address the
split in the circuits, but it appears to be a further expansion of the Mc-
Lain test. 141
review board in terminating his staff privileges led to a decline in the number of
out-of-state patients that Midway admitted. Other possible evidence would be a
demonstration that Dr. Pinhas was excluded from practicing at out-of-state hos-
pitals on the basis of Midway's negative peer review proceeding.
136. Comment, supra note 5, at 139-40. Under this test, "the plaintiff must
allege that the required effect on interstate commerce flows not simply from that
portion of the defendant's conduct that plaintiff asserts is illegal under the anti-
trust laws." Id. at 140.
137. Id. at 140. This is essentially the approach adopted by the majority of
the circuits that have addressed the issue. For a discussion of the majority's
approach, see supra note 67 and accompanying text.
138. Summit Health, Ill S. Ct. at 1847. Summit Health argued that "[Dr.
Pinhas'] complaint is insufficient because there is no factual nexus between the
restraint on this one surgeon's practice and interstate commerce." Id. See Brief
for the Petitioners at 9-10, Summit Health (No. 89-1679), reprinted in 24 Trade
Reg. Series 103, 119-20 (No. 1, 1990-1991).
139. Brief for Respondent at 5-6, Summit Health (No. 86-1679), reprinted in
24 Trade Reg. Series 103, 144-45 (No. 1, 1990-1991). Dr. Pinhas contended
that "[t]he peer review process, which controls the admission of physicians to
the hospital staff, necessarily affects the provision of hospital services because
the hospital can provide its services only through the physicians on its medical
staff." Id. at 5, reprinted in 24 Trade Reg. Series at 144. For a discussion of the
"infected activities" test, see supra notes 133-35 and accompanying text.
140. Summit Health, 111 S. Ct. at 1847.
141. For a discussion of the split among the circuits over the McLain test,
see supra notes 66-68 and accompanying text.
400 [Vol. 37: p. 373
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The majority's opinion looks neither to the restraint's ultimate ef-
fect on interstate commerce, nor to the "infected" activity's effect on
interstate commerce.' 42 Instead, the majority focuses upon the exclu-
sion of Dr. Pinhas from the Los Angeles ophthalmological services mar-
ket and how that market impacts interstate commerce. 14 3 From this
"market impact" perspective, the majority analyzes the potential harm
likely to result from the restraint's impact on potential participants in
the defined market from which Dr. Pinhas was excluded. 14 4
The majority's new standard is properly characterized as expansion-
ist. Instead of analyzing whether the defendants' general business activ-
ities or infected activities, or the defendants' alleged restraint affect
interstate commerce, the majority analyzes whether the Los Angeles
ophthalmological services market, from which Dr. Pinhas was excluded,
has a nexus with interstate commerce. Once the Court determines that
the affected market impacts interstate commerce, the Court then specu-
lates as to the potential harm suffered by current and potential partici-
pants in the infected market.' 4 5
Seemingly, the exclusion of one ophthalmologist from the Los An-
geles market area could not have a substantial effect on interstate com-
142. Summit Health, 111 S. Ct. at 1850 (Scalia, J., dissenting). As discussed
previously, a test for jurisdiction under the Act which considers the alleged re-
straint's ultimate effect on interstate commerce has been advocated by a number
of commentators. For a discussion of the "infected activities" test, see supra
notes 133-35 and accompanying text.
143. Summit Health, 111 S. Ct. at 1850 (Scalia, J., dissenting). The majority
does not appear, as does Justice Scalia, to use "market" as a term of art. Accord-
ing to Justice Scalia, the majority misinterpreted the scope of the restraint to be
the entire eye surgery market in Los Angeles. Id. at 1852 (Scalia, J., dissenting).
Instead, Justice Scalia contended that, under the standard antitrust analysis, the
alleged restraint defines the extent of the market. Id. (Scalia,J., dissenting). On
the basis of this analysis,Justice Scalia viewed the relevant market as eye surgery
at Midway, not in Los Angeles. Id. (Scalia, J., dissenting). Justice Scalia con-
tended that it was "irrational" and without basis to conclude that the alleged
restraint's market power, and its corresponding effect on competition, encom-
passed all of Los Angeles. Id. (Scalia,J., dissenting). Rather, Justice Scalia pos-
ited that the facts of Summit Health evidence the "truly local nature of the
restraint" and, therefore, the restraint had no effect on the Los Angeles market
on the whole. Id. (Scalia, J., dissenting).
144. Id. at 1848.
145. Id. at 1850 (ScaliaJ., dissenting). Justice Scalia claimed that the ma-
jority's "market" analysis was incorrect. Id. (Scalia, J., dissenting). The term
"market" is described by Justice Scalia as the "scope of other products or serv-
ices against which it must compete." Id. at 1850-51 (Scalia, J., dissenting). Jus-
tice Scalia could not understand the majority's opinion that the exclusion of a
single physician could have a market-wide effect in Los Angeles. Id. at 1851
(Scalia, J., dissenting). Instead, Justice Scalia isolated a completely different is-
sue in this case: "[W]hether the Act does apply, and that must be answered by
determining whether, in its practical economic consequences, the boycott sub-
stantially affects interstate commerce by restricting competition." Id. (Scalia, J.,
dissenting).
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merce. 1 4 6 The conspiracy undertaken by Midway's peer review board
was directed, not against all ophthalmologists in the Los Angeles mar-
ket, but against Dr. Pinhas only.14 7 Midway denied staff privileges to Dr.
Pinhas because he would not participate in its second physician require-
ment-not to obtain a monopoly in the Los Angeles ophthalmological
services market. Yet, under the "potential harm" approach advocated by
the Court, the Court is nonetheless able to conclude that such an exclu-
sion from a single hospital was sufficient to invoke the jurisdiction of the
Act. As this result suggests, and as Justice Scalia argues in his dissent,
the proper focus of a court in assessing the jurisdictional issue under the
Act should be "the nature and potential effect of each particular re-
straint," rather than the "potential harm" which might result from a sin-
gle practitioner's exclusion from the market. 148 Under this approach,
advocated by the majority of the circuits, the exclusion of Dr. Pinhas
under the circumstances indicated in the record would have a sufficient
nexus with interstate commerce to trigger jurisdiction under the Act.
Indeed, the Summit Health majority's focus on the potential harm will
likely raise new factual and definitional issues in future litigation under
the Act.
In addition, the expansion of the McLain test will allow federal law
enforcement agencies to bring actions against businesses and industries
that were previously too localized for the scope of the Sherman Act. 149
The United States, as amicus curiae in Summit Health, claimed that a vari-
ety of previously "too localized" conspiracies could be regulated, such
as "rigged bids on school milk sales, rigged auction rings, rigged bids on
local road building contracts, and rigged bids in small-scale military
procurement."l15'
For example, assume the United States brought an action under the
Act alleging that contractors in a local city rigged the bids on the con-
146. See id. at 1851 (Scalia, J., dissenting). Justice Scalia disagreed with the
majority's suggestion that competition throughout the Los Angeles ophthalmo-
logical services market was affected by Dr. Pinhas' exclusion from the market.
Id. (Scalia, J., dissenting). Justice Scalia contended that this suggestion com-
pletely ignored the "practical economics" of the issue. Id. (Scalia, J., dissent-
ing). According to Justice Scalia, the true issue was whether the Act applied,
which was answered by analyzing whether Dr. Pinhas' exclusion, "in its practical
economic sense," affected interstate commerce. Id. (Scalia, J., dissenting).
147. Dr. Pinhas stated in his amended complaint that Summit Health and
Midway had engaged in "a conspiracy to drive him out of business 'so that other
ophthalmologists and eye physicians ... will have a greater share of the eye care
and ophthalmic surgery in Los Angeles.'" Id. at 1844 (quoting Amended Com-
plaint at 122).
148. Id. at 1849 (Scalia, J., dissenting).
149. Brief for the United States as Amicus Curiae Supporting Respondent
at 14-15, Summit Health (No. 89-1679), reprinted in 24 Trade Reg. Series 267, 286-
87 (No. 1, 1990-1991) [hereinafter Brief for the United States].
150. Brief for the United States at 15, reprinted in 24 Trade Reg. Series at
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struction of a municipal office building. Under Summit Health, the Justice
Department could allege that the bid rigging conspiracy affects inter-
state commerce because the line of business (construction) necessarily
affects interstate commerce, even though the individual transaction
might have only a localized impact. 1 5 Summit Health's expansion of the
McLain test will provide the Justice Department with an effective en-
forcement weapon, since it will likely provide a gateway into new areas
of antitrust enforcement and regulation that were previously too local-
ized for the Act's jurisdictional scope.
B. A Practical Approach to Obtaining Jurisdiction Under the Act After
Summit Health
Instead of settling the split in the circuits over the jurisdictional
scope of the Act by selecting one of the previously enumerated tests, 152
the Summit Health Court settled the split by removing any jurisdictional
hurdle to securing federal jurisdiction under the Act. The Court's new
interpretation of the McLain standard, which previously required a
showing that the infected activities have a "not insubstantial effect" on
interstate commerce "as a matter of practical economics," substantially
expands the Act's jurisdictional scope.153
Using this new formulation, a plaintiff can now establish jurisdiction
under the Act by simply averring that the alleged restraint, if successful,
would have an impact on other potential competitors in the market from
which the plaintiff was excluded. 154 Under Summit Health, a plaintiff, to
obtain jurisdiction under the Act, need only aver that the market, in-
fected by the illegal restraint, affects interstate commerce. An averment
of an actual effect on interstate commerce is no longer necessary to sup-
port federal jurisdiction under the Act. 15 5 This formulation for all in-
tents and purposes abolishes the jurisdictional hurdle of the Act,
because today a plaintiff can easily aver that nearly all commercial enti-
ties have some effect on interstate commerce.
One cautionary note is that lower courts may continue to use the
previously identified jurisdictional tests to draw arbitrary distinctions in
order to prevent multitudes of new plaintiffs, attempting to gain the
benefits of federal jurisdiction, from alleging violations of the Act. It
151. See Perez v. United States, 402 U.S. 146 (1971) (petitioner, appealing
his conviction of loansharking, claimed two extortionate loans had no interstate
commerce impact). The Court held that even if the individual transaction has
only intrastate effects, the Court has jurisdiction over the action if the "class of
activity" in the aggregate impacts interstate commerce. Id. at 154-55.
152. For a complete discussion of the identified tests resulting from the
Court's opinion in McLain, see supra notes 125-37 and accompanying text.
153. McLain, 444 U.S. 232, 246 (1980). For a detailed discussion of Mc-
Lain, see supra notes 56-65 and accompanying text.
154. Summit Health, 111 S. Ct. at 1848 (citing McLain, 444 U.S. at 242-43).
155. Id. (citing McLain, 444 U.S. at 242-43).
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could be that the existing circuit split over the jurisdictional reach of the
Act has developed in response to the Court's continued expansion of
the jurisdictional reach of the Act. After Summit Health, a majority of the
Court appears to be intent on providing jurisdiction under the Act to
any plaintiff averring that an alleged restraint produces even the slight-
est nexus with interstate commerce.
C. Application of the Act to the Health Care Industry After Summit Health
Moreover, as the facts of Summit Health demonstrate, the expansion
of the Act's jurisdiction following Summit Health will have a direct impact
upon the health care industry. As the health care industry has become
more competitive, hospitals have attempted to provide a higher quality
of care at a lower price.' 5 6 This added competitive pressure has had a
profound influence on the operation of many hospitals. 15 7 One such
area which has been influenced by these pressures is the granting of
medical staff privileges at many hospitals. 15 8 Staff privileges at many
hospitals are controlled by a peer review board. 159 The competitive
pressures of the industry have forced many hospitals and peer review
boards to become more restrictive with their staff privileges. 160 As a
156. Ann R. Gough, Note, Quality of Care, Staff Privileges, and Antitrust Law, 64
U. DET. L. REV. 505, 505 (1987). Hospitals have faced pressure from three
sources: the public, the government, and the courts. Id. at 505-06.
157. Gough, supra note 156, at 505. These competitive pressures have re-
sulted in hospitals becoming more restrictive in granting medical staff privileges
to physicians. For a complete discussion of medical staff privileges, see infra
note 158 and accompanying text.
158. Gough, supra note 156, at 505-06. The term "staff privileges" gener-
ally refers to the right of a physician to admit patients and to perform medical
procedures at the hospital. See id. at 505-07. Staff privileges are a scarce but
vital commodity for any doctor, because these privileges are hard to obtain, giv-
ing an attending physician the right to admit patients and to use a hospital's
facilities and equipment. Kissam et al., supra note 132, at 598. "Attending phy-
sicians are not salaried employees but rather unique kinds of independent con-
tractors, who obtain the privilege of admitting and treating patients in the
hospital in return for a commitment to perform some hospital work .... Id. at
606.
159. Gough, supra note 156, at 507. Although custom varies from hospital
to hospital, many hospitals have adopted by-laws that provide for minimum ac-
creditation standards for its attending physicians. Kissam et al., supra note 132,
at 606. These standards generally conform to the guidelines promulgated by
the Joint Commission for Accreditation of Healthcare Organizations. Id. Gen-
erally, a peer review board, consisting of members of the medical staff, evaluates
the hospital's medical staff and makes recommendations regarding staff privi-
leges to the hospital's governing board. Id. A peer review board examines each
physician's resume "to determine the extent of his past medical training and
performance, whether he is licensed and board certified, whether he carries mal-
practice insurance, and any other information that they believe is relevant."
John Neff, Note, Physician Staff Privilege Cases: Antitrust Liability and the Health Care
Quality Improvement Act, 29 WM. & MARY L. REV. 609, 613-14 (1988).
160. William Carlson, Physician Credentialing Decisions and the Sherman Act, 18
CUMB. L. REV. 419, 419-20 (1988). Hospitals could foreseeably reject a physi-
[Vol. 37: p. 373
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result, many hospitals and their peer review boards have become de-
fendants to antitrust actions brought by physicians who have been de-
nied staff privileges by that hospital.' 6' These cases have generally been
referred to as "hospital staff exclusion" cases. 16 2
As in other cases under the Act, the threshold issue in exclusion
cases is whether the alleged restraint has any sufficient nexus with inter-
state commerce to invoke the jurisdiction of the Act. 163 Hospitals have
become increasingly cognizant of this potential liability, since courts
have held that some activities of a hospital, no matter how local in na-
ture, can have a sufficient effect on interstate commerce to support an
antitrust claim. 164 The Summit Health Court's expansion of the interstate
cian's application for medical staff privileges because the current medical staff
wants to maintain its current competitive advantage over access to the hospital's
facilities. Id. at 420.
161. See, e.g., Mitchell v. Frank R. Howard Memorial Hosp., 853 F.2d 762
(9th Cir. 1988) (radiologist Mitchell brought antitrust claim against hospital af-
ter its termination of oral employment agreement); Shahaway v. Harrison, 778
F.2d 636 (11 th Cir. 1985) (antitrust claim against defendant hospital committee
and officers over denial of staff privileges), amended, 790 F.2d 75 (11th Cir.
1986); Seglin v. Esau, 769 F.2d 1274 (7th Cir. 1985) (antitrust claim after denial
of staff privileges by hospital's peer review board); Cardio-Medical Assocs., Ltd.
v. Crozer-Chester Medical Center, 721 F.2d 68 (3d Cir. 1983) (antitrust claim
based on denial of hospital staff privileges).
The exclusion of a physician from practicing at a hospital can have serious
and detrimental professional repercussions on the physician's career and reputa-
tion. Kissam et al., supra note 132, at 599-600.
Anything more than minimal involvement by the medical staff in the
final decision [to deny staff privileges], which is made by governing
[board], can be construed as a conspiracy to exclude a competing physi-
cian from the benefits of staff membership. Staff members may advo-
cate denial of privileges based on reasons unconnected with the
physician's professional qualifications. If the hospital then relies on the
staff not only for its opinion of the physician's skills but also for a rec-
ommendation on whether to approve or deny the physician's applica-
tion, an illegal conspiracy may exist.
Neff, supra note 159, at 619-20. "Because staff privileges are of major economic
importance to doctors, a physician who has been denied staff privileges may
bring suit to contest a hospital's action." Id. at 614.
162. Comment, supra note 5, at 123. Generally, these cases are brought by
physicians, under § 1 of the Act, challenging their denial of staff privileges as an
attempt by the hospital or peer review board to monopolize the market by boy-
cotting competing medical practitioners, or foreclosing competition in special-
ized medical services, and controlling access to facilities essential to a medical
practice. Id. at 122. For a discussion of such cases, see supra note 161 and ac-
companying text.
163. Comment, supra note 5, at 126-28.
164. Hospital Bldg. Co. v. Trustees of Rex Hosp., 425 U.S. 738, 739-40
(1976). These actions typically allege that hospitals and their peer review
boards have conspired to boycott certain doctors, "monopolize local markets or
foreclose competition in specialized medical services, and control access to facil-
ities essential to a medical practice." Comment, supra note 5, at 122; see, e.g.,
Stone v. William Beaumont Hosp., 782 F.2d 609, 611 (6th Cir. 1986) (plaintiff
alleged denial of his application for staff privileges due to concerted activity by
defendants violating federal and state antitrust laws); Seglin, 769 F.2d at 1275
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commerce test for jurisdiction under the Act is likely to subject hospitals
to far more expensive litigation. 16 5 The increase in litigation will likely
result in a substantial rise in a hospital's insurance premiums, and these
additional costs will only make health care more expensive.
Furthermore, the expansion of the jurisdictional test appears to
lessen the impact of the Health Care Quality Improvement Act of 1986
(HCQIA).' 66 This federal legislation provides peer review boards with
a potential defense to antitrust claims from physicians denied staff privi-
leges. 16 7 HCQIA provides qualified immunity from private actions
under federal and state law.168 However, before the antitrust immunity
attaches, a peer review board must establish that it has adhered to the
professional peer review guidelines provided in HCQIA. 169
The legislative intent behind HCQIA was to promote effective peer
(physician, denied staff privileges, sued hospital's peer review board members
alleging defendants "conspired and combined to violate sections 1 and 2 of the
Sherman Antitrust Act"); Cardio-MedicalAssocs., 721 F.2d at 71 (plaintiffs alleged
defendants hospital and physicians entered into illegal contracts "to prevent
plaintiffs from using certain of defendants' specialized cardiological equip-
ment"); Crane v. Intermountain Health Care, Inc., 637 F.2d 715, 719 (10th Cir.
1981) (plaintiff alleged defendants conspired to exclude him from performing
pathology services at defendants' facilities).
165. Brief for the Petitioners at 19-20, Summit Health (No. 89-1679), reprinted
in 24 Trade Reg. Series 103, 129-30 (No. 1, 1990-1991). Summit Health and
Midway contended that the elimination of the Act's jurisdictional test would sub-
ject hospitals and their medical staffs to costly antitrust litigation. Id. Summit
Health and Midway claim that, more often than not, physicians will choose to
sue under federal antitrust law rather than state antitrust law or other available
remedies because of the Act's threat of treble damages, and to avoid the pros-
pect of "state law discovery privileges and immunities imposed by the states in
regulating their peer review activities." Id. at 130.
166. Health Care Quality Improvement Act of 1986, 42 U.S.C.A. §§ 11101-
52 (West Supp. 1992).
167. See id. § 1111 l(a)(1). This section provides that if a peer review pro-
ceeding conforms to the established procedures, the participants "shall not be
liable in damages under any law of the United States or of any State (or political
subdivision thereof) with respect to the action." Id.
168. Susan L. Horner, The Health Care Quality Improvement Act of 1986: Its
History, Provisions, Applications and Implications, 16 AM. J.L. & MED. 453, 467
(1990). "The immunity applies to members who take action that adversely af-
fects clinical privileges of a practitioner, if such action is taken with the reason-
able belief that it is necessary to further quality of health care." Id.
169. See 42 U.S.C.A. § 11112(a). Peer review action must be taken:
(1) in the reasonable belief that the action was in the furtherance of
quality health care,
(2) after a reasonable effort to obtain the facts of the matter,
(3) after adequate notice and hearing procedures are afforded to the
physician involved or after such other procedures as are fair to the phy-
sician under the circumstances, and
(4) in the reasonable belief that the action was warranted by the facts
known after such reasonable effort to obtain facts and after meeting the
requirement of paragraph (3).
406
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review by protecting physicians from antitrust liability in their perform-
ance of peer review duties. 170 One of Congress' findings stated that
"[t]he threat of private money damage liability under Federal laws, in-
cluding treble damage liability under Federal antitrust law, unreasona-
bly discourages physicians from participating in effective peer
review." 171
In Summit Health, it was established that the required interstate com-
merce nexus can be established by averring that the line of business in-
fected by the restraint impacts interstate commerce. 172 Under the Act,
however, this expansion of the jurisdictional standard by the Summit
Health Court will allow less deserving plaintiffs to simply allege that his
or her denial of staff privileges by a review board entitles the plaintiff to
bring the case to trial. The finding that peer review proceedings affect
interstate commerce will definitely impede the practice of effective peer
review procedures in hospitals nationwide.
V. CONCLUSION
In order to settle the confusion generated by the courts of appeals
following McLain, the Court in Summit Health should have adopted a sin-
gle standard that evenly weighs the competing concerns of providing
170. Id. § 11101. Congress relied upon the following findings of fact in
enacting HCQIA:
(1) The increasing occurrence of medical malpractice and the need to
improve the quality of medical care have become nationwide problems
(2) There is a national need to restrict the ability of incompetent physi-
cians to move from State to State without disclosure or discovery of the
physician's previous damaging or incompetent performance.
(3) This nationwide problem can be remedied through effective profes-
sional peer review.
(4) The threat of private money damage liability under Federal laws,
including treble damage liability under Federal antitrust law, unreason-
ably discourages physicians from participating in effective peer review.
Id.
171. Id. § 11101. Representative Waxman of California, sponsor of the
HCQIA, stated in House deliberations on the bill that
[t]he limited immunity [provisions of] this bill [are] essential to en-
courage physicians and hospitals to participate in conducting effective
peer review. The immunity provisions have been restricted so as not to
protect illegitimate actions taken under the guise of furthering the
quality of health care. Actions ... that are really taken for anticompeti-
tive purposes will not be protected under this bill.
132 CONG. REC. H9957 (daily ed. Oct. 14, 1986) (statement of Rep. Waxman).
During the hearings, Congress stated that "[u]nlike other activities that may
trigger antitrust lawsuits, properly limited peer review plays no essential or im-
portant economic role in the practice of medicine. Doctors who are sufficiently
fearful of the threat of litigation will simply not do meaningful peer review."
H.R. REP. No. 903, 99th Cong., 2nd Sess. 3 (1986), reprinted in 1986
U.S.C.C.A.N. 6384, 6385.
172. For a further discussion of the Summit Health majority's holding, see
supra notes 96-112 and accompanying text.
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injured plaintiffs a forum for recovery, while protecting business from
unsubstantiated antitrust claims. However, the Summit Health Court did
not do this. Rather, the Court further expanded the scope of the Act's
jurisdiction by formulating an entirely new jurisdictional standard. One
negative ramification of this new rule is that less deserving plaintiffs will
be able to secure jurisdiction under the Act. However, this expansion
provides a means for the Justice Department to inject a competitive ele-
ment into numerous lines of business that were previously considered
too localized for jurisdiction under the Act.73
An acceptable rule that balances these competing interests is neces-
sary. Such a rule would be one similar to the standard used prior to
Summit Health by the majority of the circuits.1 74 Such a test would better
protect, for example, the interests of the hospital in performing effective
peer review, while protecting the plaintiff against illegal restraints. 175
Jurisdiction under the Act should only be found if the plaintiff al-
leges a more profound effect on interstate commerce. Justice Scalia ap-
peared to have these competing interests in mind when he advocated
returning to the more stringent pre-McLain test that asked whether the
illegal restraint, "if successful, would have a substantial effect on inter-
state commerce."
176
William F. Detwiler
173. Indeed, the ability of the government to reach purely local activities
under the Act should enhance local competition. Specifically, by expanding the
Act to purely local activities, local competitors will operate under the threat of
criminal and civil prosecution should they engage in price-fixing, conspiracies,
or any other illegal restraint. Applying this theory specifically to the health care
industry, James Rill, Assistant Attorney General of the Antitrust Division of the
United States Department ofJustice, stated "[f]or competition to take hold, the
market must be allowed to operate free of the illegal exercise of market power.
Competition is our best vehicle for curbing spiraling health care costs, and anti-
trust enforcement is the most efficient and least intrusive method of preserving
the market for competition." James F. Rill, Health Care Cost Containment and
Competition, Address Before "A Day with Justice," A Symposium of the Na-
tional Legal Center for the Public Interest (Apr. 23, 1991) at 2-3.
174. For a discussion of the rule adopted by the majority of the circuit
courts, see supra note 67 and accompanying text.
175. See Summit Health, 111 S. Ct. 1842, 1853-54 (Scalia, J., dissenting).
176. Id. at 1849 (Scalia, J., dissenting).
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